Selective atomic layer etching of semiconductor materials

Abstract
Precursors, such as interhalogens and/or compounds formed of noble gases and halogens, may be supplied in a gaseous form to a semiconductor processing chamber at a predetermined amount, flow rate, pressure, and/or temperature in a cyclic manner such that atomic layer etching of select semiconductor materials may be achieved in each cycle. In the etching process, the element of the precursor that has a relatively higher electronegativity may react with select semiconductor materials to form volatile etching byproducts. The element of the precursor that has a relatively lower electronegativity may form a gas that may be recycled to re-form an precursor with one or more halogen-containing materials using a plasma process.
Description
TECHNICAL FIELD

The present technology relates to semiconductor processes and equipment. More specifically, the present technology relates to methods and systems for isotropic atomic or molecular layer etching of materials used in semiconductor processing.


BACKGROUND

Integrated circuits are made possible by processes which produce intricately patterned material layers on substrate surfaces. Producing patterned material on a substrate requires controlled methods for removal of exposed material. Chemical etching is used for a variety of purposes including transferring a pattern in photoresist into underlying layers, thinning layers, or thinning lateral dimensions of features already present on the surface. Often it is desirable to have an etch process that etches one material faster than another facilitating, for example, a pattern transfer process. Such an etch process is said to be selective to the first material. As a result of the diversity of materials, circuits, and processes, etch processes have been developed with a selectivity towards a variety of materials.


Etch processes may be termed wet or dry based on the materials used in the process. A wet HF etch preferentially removes silicon oxide over other dielectrics and materials. However, wet processes may have difficulty penetrating some constrained trenches and also may sometimes deform the remaining material. Dry etches produced in local plasmas formed within the substrate processing region can penetrate more constrained trenches and exhibit less deformation of delicate remaining structures. However, local plasmas may damage the substrate through the production of electric arcs as they discharge.


Thus, there is a need for improved systems and methods that can be used to produce high quality devices and structures. These and other needs are addressed by the present technology.


SUMMARY

Exemplary etching methods may include flowing a halogen-containing precursor into a processing region of a semiconductor processing chamber. The methods may further include contacting an exposed region of a semiconductor material with the halogen-containing precursor such that the halogen-containing precursor may be adsorbed on a surface of the exposed region of the semiconductor material. The methods may also include forming a film of the halogen-containing precursor having a predetermined thickness on the surface of the exposed region of the semiconductor material. The methods may further include pausing the flow of the halogen-containing precursor into the processing region of the semiconductor processing chamber. The methods may also include etching the exposed region of the semiconductor material with the adsorbed halogen-containing precursor. The adsorbed halogen-containing precursor may produce a fluoride of the semiconductor material. In some embodiments, the method may further include purging the halogen-containing precursor not adsorbed on the surface of the exposed region of the semiconductor material.


In some embodiments, the film of the halogen-containing precursor formed on the surface of the exposed region of the semiconductor material may include an atomic layer of the halogen-containing precursor. In some embodiments, etching the exposed region of the semiconductor material may include isotropically etching the exposed region of the semiconductor material. In some embodiments, the adsorbed halogen-containing precursor may produce a noble gas. In some embodiments, the halogen-containing precursor may include at least one of a noble gas compound precursor, an interhalogen precursor, or a fluorinating precursor. In some embodiments, the semiconductor material may include at least one of silicon, germanium, or a compound thereof. In some embodiments, a temperature of the substrate may be maintained at about room temperature. In some embodiments, the etching method may be repeated for at least two cycles. In some embodiments, a thickness of the semiconductor material etched during each cycle may be between about 5 Å and about 50 Å. In some embodiments, the etching method may have a selectivity toward the semiconductor material to a metal-containing material greater than or about 50:1. In some embodiments, the metal-containing material may include at least one of titanium, titanium nitride, tantalum, tantalum nitride, tungsten, or titanium tungsten. In some embodiments, a pressure within the semiconductor processing chamber may be maintained between about 5 mTorr and about 50 Torr.


The present technology may also include additional exemplary etching methods. The methods may include flowing a halogen-containing precursor into a processing region of a semiconductor processing chamber. The methods may further include contacting an exposed region of a metal-containing material with the halogen-containing precursor such that the halogen-containing precursor may be adsorbed on a surface of the exposed region of the metal-containing material. The methods may further include forming a film of the halogen-containing precursor on the surface of the exposed region of the metal-containing material. The methods may also include pausing the flow of the halogen-containing precursor into the processing region of the semiconductor processing chamber. The methods may further include etching the exposed region of the metal-containing material with the adsorbed halogen-containing precursor. The adsorbed halogen-containing precursor may produce a fluoride of the metal-containing material.


In some embodiments, the methods may further include purging the halogen-containing precursor not adsorbed on the surface of the exposed region of the metal-containing material such that an atomic layer of the halogen-containing precursor may be produced on the surface of the exposed region of the metal-containing material. In some embodiments, a temperature of the substrate may be maintained between about room temperature and about 300° C. In some embodiments, the metal-containing material may include at least one of molybdenum, titanium, titanium nitride, tantalum, tantalum nitride, tungsten, or titanium tungsten. In some embodiments, the halogen-containing precursor may include XeF2.


In some embodiments, the methods may further include contacting an exposed region of a semiconductor material with the halogen-containing precursor such that the halogen-containing precursor may be adsorbed on a surface of the exposed region of the semiconductor material. The methods may further include forming a film of the halogen-containing precursor on the surface of the exposed region of the semiconductor material. The methods may also include pausing the flow of the halogen-containing precursor into the processing region of the semiconductor processing chamber. The methods may further include etching the exposed region of the semiconductor material with the adsorbed halogen-containing precursor on the surface of the exposed region of the semiconductor material. The adsorbed halogen-containing precursor may produce a fluoride of the semiconductor material.


The present technology may also include additional exemplary etching methods. The methods may include flowing a first halogen-containing precursor into a processing region of a semiconductor processing chamber. The first halogen-containing precursor may include a noble gas compound precursor. The methods may further include contacting an exposed region of a semiconductor material with the first halogen-containing precursor such that the first halogen-containing precursor may be adsorbed on a surface of the exposed region of the semiconductor material. The methods may further include etching the exposed region of the semiconductor material with the adsorbed first halogen-containing precursor. The adsorbed first halogen-containing precursor may produce a gaseous byproduct. The methods may also include forming a second halogen-containing precursor from the gaseous byproduct using plasma.


In some embodiments, the methods may further include flowing the second halogen-containing precursor into the processing region of the semiconductor processing chamber. The methods may also include contacting the exposed region of the semiconductor material with the second halogen-containing precursor such that the second halogen-containing precursor may be adsorbed on the surface of the exposed region of the semiconductor material. In some embodiments, the methods may further include etching the exposed region of the semiconductor material with the adsorbed second halogen-containing precursor. The adsorbed second halogen-containing precursor may produce a fluoride of the semiconductor material. In some embodiments, the gaseous byproduct may include at least one of a noble gas or a halogen gas.


Such technology may provide numerous benefits over conventional systems and techniques. For example, the technology may allow for highly selective etching towards semiconductor materials over a wide variety of metals, oxides, nitrides, carbides, and/or organic compounds commonly used in semiconductor processing. The technology may also allow for highly selective etching of select metal-containing materials at elevated temperatures. The high selectivity offered by the technology may further allow very thin mask materials to be used. Additionally, the technology may allow for very controlled delivery of precursors and may achieve atomic or molecular layer etching of select semiconductor and metal-containing materials to improve the uniformity of the etched profile. Further, the technology may allow for isotropic etching of semiconductor materials from all crystal planes. Moreover, the technology may be more economical by collecting and reusing select etch byproducts. These and other embodiments, along with many of their advantages and features, are described in more detail in conjunction with the below description and attached figures.





BRIEF DESCRIPTION OF THE DRAWINGS

A further understanding of the nature and advantages of the disclosed technology may be realized by reference to the remaining portions of the specification and the drawings.



FIG. 1 shows a top plan view of one embodiment of an exemplary processing system according to embodiments of the present technology.



FIG. 2A shows a schematic cross-sectional view of an exemplary processing chamber according to embodiments of the present technology.



FIG. 2B shows a detailed view of a portion of the processing chamber illustrated in FIG. 2A according to embodiments of the present technology.



FIG. 3 shows a bottom plan view of an exemplary showerhead according to embodiments of the present technology.



FIG. 4 shows exemplary operations in a method according to embodiments of the present technology.



FIGS. 5A-5D show cross-sectional views of substrates being processed according to embodiments of the present technology.



FIG. 6 shows a schematic view of an exemplary precursor delivery system according to embodiments of the present technology.



FIG. 7 shows exemplary operations in a method according to embodiments of the present technology.



FIG. 8 shows exemplary operations in a method according to embodiments of the present technology.





Several of the figures are included as schematics. It is to be understood that the figures are for illustrative purposes, and are not to be considered of scale unless specifically stated to be of scale. Additionally, as schematics, the figures are provided to aid comprehension and may not include all aspects or information compared to realistic representations, and may include exaggerated material for illustrative purposes.


In the appended figures, similar components and/or features may have the same reference label. Further, various components of the same type may be distinguished by following the reference label by a letter that distinguishes among the similar components. If only the first reference label is used in the specification, the description is applicable to any one of the similar components having the same first reference label irrespective of the letter.


DETAILED DESCRIPTION

The selectivity of conventional wet chemistry etching processes for etching silicon relative to other materials is generally low. In addition, the wet chemistry etching processes can also be crystallographic, which means that etching of silicon may not be the same at different cyrstal planes. For example, etching of silicon at silicon crystal planes of (110), (111) or along the <110>, <111> direction may be so slow that the etching process may be substantially stopped at these crystal planes or surfaces, which results in roughness in the etched profile. Low selectivity toward silicon and crystallographic etching are also common problems many dry etching processes encounter.


The present technology overcomes these issues by utilizing one or more halogen-containing persursors that may be highly selective towards silicon over a wide variety of metals, oxides, nitrides, carbides, and/or organic compounds commonly used in semiconductor processing. The halogen-containing precursors may also allow for isotropic etching of semiconductor materials from all crystal planes. The technology further overcomes the issues associated with the conventional etching processes by controlling the delivery of the precursors to achieve atomic or molecular layer etching and to obtain uniformity in the etched profile. Further, the present technology may be plasma free, which may limit damage to the substrate features many conventional dry etching methods may cause. These and other embodiments, along with many of their advantages and features, are described in more detail in conjunction with the below description and attached figures.


Although the remaining disclosure will routinely identify specific etching processes utilizing the disclosed technology, it will be readily understood that the systems and methods are equally applicable to deposition and cleaning processes as may occur in the described chambers. Accordingly, the technology should not be considered to be so limited as for use with etching processes or chambers alone. Moreover, although an exemplary chamber is described to provide foundation for the present technology, it is to be understood that the present technology can be applied to virtually any semiconductor processing chamber that may allow the single-chamber operations described.



FIG. 1 shows a top plan view of one embodiment of a processing system 100 of deposition, etching, baking, and curing chambers according to embodiments. In the figure, a pair of front opening unified pods (FOUPs) 102 supply substrates of a variety of sizes that are received by robotic arms 104 and placed into a low pressure holding area 106 before being placed into one of the substrate processing chambers 108a-f, positioned in tandem sections 109a-c. A second robotic arm 110 may be used to transport the substrate wafers from the holding area 106 to the substrate processing chambers 108a-f and back. Each substrate processing chamber 108a-f, can be outfitted to perform a number of substrate processing operations including the dry etch processes described herein in addition to cyclical layer deposition (CLD), atomic layer deposition (ALD), chemical vapor deposition (CVD), physical vapor deposition (PVD), etch, pre-clean, degas, orientation, and other substrate processes.


The substrate processing chambers 108a-f may include one or more system components for depositing, annealing, curing and/or etching a dielectric or metallic film on the substrate wafer. In one configuration, two pairs of the processing chambers, e.g., 108c-d and 108e-f, may be used to deposit material on the substrate, and the third pair of processing chambers, e.g., 108a-b, may be used to etch the deposited material. In another configuration, all three pairs of chambers, e.g., 108a-f, may be configured to etch a dielectric or metallic film on the substrate. Any one or more of the processes described may be carried out in chamber(s) separated from the fabrication system shown in different embodiments. It will be appreciated that additional configurations of deposition, etching, annealing, and curing chambers for dielectric films are contemplated by system 100.



FIG. 2A shows a cross-sectional view of an exemplary process chamber system 200 with partitioned plasma generation regions within the processing chamber. During film etching, e.g., titanium nitride, tantalum nitride, tungsten, copper, cobalt, silicon, polysilicon, silicon oxide, silicon nitride, silicon oxynitride, silicon oxycarbide, etc., a process gas may be flowed into the first plasma region 215 through a gas inlet assembly 205. A remote plasma system (RPS) 201 may optionally be included in the system, and may process a first gas which then travels through gas inlet assembly 205. The inlet assembly 205 may include two or more distinct gas supply channels where the second channel (not shown) may bypass the RPS 201, if included.


A cooling plate 203, faceplate 217, ion suppressor 223, showerhead 225, and a substrate support 265, having a substrate 255 disposed thereon, are shown and may each be included according to embodiments. The pedestal 265 may have a heat exchange channel through which a heat exchange fluid flows to control the temperature of the substrate, which may be operated to heat and/or cool the substrate or wafer during processing operations. The wafer support platter of the pedestal 265, which may comprise aluminum, ceramic, or a combination thereof, may also be resistively heated in order to achieve relatively high temperatures, such as from up to or about 100° C. to above or about 600° C., using an embedded resistive heater element.


The faceplate 217 may be pyramidal, conical, or of another similar structure with a narrow top portion expanding to a wide bottom portion. The faceplate 217 may additionally be flat as shown and include a plurality of through-channels used to distribute process gases. Plasma generating gases and/or plasma excited species, depending on use of the RPS 201, may pass through a plurality of holes, shown in FIG. 2B, in faceplate 217 for a more uniform delivery into the first plasma region 215.


Exemplary configurations may include having the gas inlet assembly 205 open into a gas supply region 258 partitioned from the first plasma region 215 by faceplate 217 so that the gases/species flow through the holes in the faceplate 217 into the first plasma region 215. Structural and operational features may be selected to prevent significant backflow of plasma from the first plasma region 215 back into the supply region 258, gas inlet assembly 205, and fluid supply system 210. The faceplate 217, or a conductive top portion of the chamber, and showerhead 225 are shown with an insulating ring 220 located between the features, which allows an AC potential to be applied to the faceplate 217 relative to showerhead 225 and/or ion suppressor 223. The insulating ring 220 may be positioned between the faceplate 217 and the showerhead 225 and/or ion suppressor 223 enabling a capacitively coupled plasma (CCP) to be formed in the first plasma region. A baffle (not shown) may additionally be located in the first plasma region 215, or otherwise coupled with gas inlet assembly 205, to affect the flow of fluid into the region through gas inlet assembly 205.


The ion suppressor 223 may comprise a plate or other geometry that defines a plurality of apertures throughout the structure that are configured to suppress the migration of ionically-charged species out of the first plasma region 215 while allowing uncharged neutral or radical species to pass through the ion suppressor 223 into an activated gas delivery region between the suppressor and the showerhead. In embodiments, the ion suppressor 223 may comprise a perforated plate with a variety of aperture configurations. These uncharged species may include highly reactive species that are transported with less reactive carrier gas through the apertures. As noted above, the migration of ionic species through the holes may be reduced, and in some instances completely suppressed. Controlling the amount of ionic species passing through the ion suppressor 223 may advantageously provide increased control over the gas mixture brought into contact with the underlying wafer substrate, which in turn may increase control of the deposition and/or etch characteristics of the gas mixture. For example, adjustments in the ion concentration of the gas mixture can significantly alter its etch selectivity, e.g., SiNx:SiOx etch ratios, Si:SiOx etch ratios, etc. In alternative embodiments in which deposition is performed, it can also shift the balance of conformal-to-flowable style depositions for dielectric materials.


The plurality of apertures in the ion suppressor 223 may be configured to control the passage of the activated gas, i.e., the ionic, radical, and/or neutral species, through the ion suppressor 223. For example, the aspect ratio of the holes, or the hole diameter to length, and/or the geometry of the holes may be controlled so that the flow of ionically-charged species in the activated gas passing through the ion suppressor 223 is reduced. The holes in the ion suppressor 223 may include a tapered portion that faces the plasma excitation region 215, and a cylindrical portion that faces the showerhead 225. The cylindrical portion may be shaped and dimensioned to control the flow of ionic species passing to the showerhead 225. An adjustable electrical bias may also be applied to the ion suppressor 223 as an additional means to control the flow of ionic species through the suppressor.


The ion suppressor 223 may function to reduce or eliminate the amount of ionically charged species traveling from the plasma generation region to the substrate. Uncharged neutral and radical species may still pass through the openings in the ion suppressor to react with the substrate. It should be noted that the complete elimination of ionically charged species in the reaction region surrounding the substrate may not be performed in embodiments. In certain instances, ionic species are intended to reach the substrate in order to perform the etch and/or deposition process. In these instances, the ion suppressor may help to control the concentration of ionic species in the reaction region at a level that assists the process.


Showerhead 225 in combination with ion suppressor 223 may allow a plasma present in first plasma region 215 to avoid directly exciting gases in substrate processing region 233, while still allowing excited species to travel from chamber plasma region 215 into substrate processing region 233. In this way, the chamber may be configured to prevent the plasma from contacting a substrate 255 being etched. This may advantageously protect a variety of intricate structures and films patterned on the substrate, which may be damaged, dislocated, or otherwise warped if directly contacted by a generated plasma. Additionally, when plasma is allowed to contact the substrate or approach the substrate level, the rate at which oxide species etch may increase. Accordingly, if an exposed region of material is oxide, this material may be further protected by maintaining the plasma remotely from the substrate.


The processing system may further include a power supply 240 electrically coupled with the processing chamber to provide electric power to the faceplate 217, ion suppressor 223, showerhead 225, and/or pedestal 265 to generate a plasma in the first plasma region 215 or processing region 233. The power supply may be configured to deliver an adjustable amount of power to the chamber depending on the process performed. Such a configuration may allow for a tunable plasma to be used in the processes being performed. Unlike a remote plasma unit, which is often presented with on or off functionality, a tunable plasma may be configured to deliver a specific amount of power to the plasma region 215. This in turn may allow development of particular plasma characteristics such that precursors may be dissociated in specific ways to enhance the etching profiles produced by these precursors.


A plasma may be ignited either in chamber plasma region 215 above showerhead 225 or substrate processing region 233 below showerhead 225. Plasma may be present in chamber plasma region 215 to produce the radical precursors from an inflow of, for example, a fluorine-containing precursor or other precursor. An AC voltage typically in the radio frequency (RF) range may be applied between the conductive top portion of the processing chamber, such as faceplate 217, and showerhead 225 and/or ion suppressor 223 to ignite a plasma in chamber plasma region 215 during deposition. An RF power supply may generate a high RF frequency of 13.56 MHz but may also generate other frequencies alone or in combination with the 13.56 MHz frequency.



FIG. 2B shows a detailed view 253 of the features affecting the processing gas distribution through faceplate 217. As shown in FIGS. 2A and 2B, faceplate 217, cooling plate 203, and gas inlet assembly 205 intersect to define a gas supply region 258 into which process gases may be delivered from gas inlet 205. The gases may fill the gas supply region 258 and flow to first plasma region 215 through apertures 259 in faceplate 217. The apertures 259 may be configured to direct flow in a substantially unidirectional manner such that process gases may flow into processing region 233, but may be partially or fully prevented from backflow into the gas supply region 258 after traversing the faceplate 217.


The gas distribution assemblies such as showerhead 225 for use in the processing chamber section 200 may be referred to as dual channel showerheads (DCSH) and are additionally detailed in the embodiments described in FIG. 3. The dual channel showerhead may provide for etching processes that allow for separation of etchants outside of the processing region 233 to provide limited interaction with chamber components and each other prior to being delivered into the processing region.


The showerhead 225 may comprise an upper plate 214 and a lower plate 216. The plates may be coupled with one another to define a volume 218 between the plates. The coupling of the plates may be so as to provide first fluid channels 219 through the upper and lower plates, and second fluid channels 221 through the lower plate 216. The formed channels may be configured to provide fluid access from the volume 218 through the lower plate 216 via second fluid channels 221 alone, and the first fluid channels 219 may be fluidly isolated from the volume 218 between the plates and the second fluid channels 221. The volume 218 may be fluidly accessible through a side of the gas distribution assembly 225.



FIG. 3 is a bottom view of a showerhead 325 for use with a processing chamber according to embodiments. Showerhead 325 may correspond with the showerhead 225 shown in FIG. 2A. Through-holes 365, which show a view of first fluid channels 219, may have a plurality of shapes and configurations in order to control and affect the flow of precursors through the showerhead 225. Small holes 375, which show a view of second fluid channels 221, may be distributed substantially evenly over the surface of the showerhead, even amongst the through-holes 365, and may help to provide more even mixing of the precursors as they exit the showerhead than other configurations.


The chambers discussed previously may be used in performing exemplary methods including etching methods. Turning to FIG. 4 is shown exemplary operations in a method 400 according to embodiments of the present technology. Prior to the first operation of the method, a substrate may be processed in one or more ways before being placed within a processing region of a chamber in which method 400 may be performed. For example, films or layers may be deposited, grown, or otherwise formed on the substrates, and masks for patterning the films or layers may be formed to produce features. Vias, trenches, and/or lateral recesses may be formed or defined within the substrate. The vias or trenches may have an aspect ratio, or a ratio of their height to width, greater than or about 2, greater than or about 5, greater than or about 10, greater than or about 20, greater than or about 30, greater than or about 50, or more in embodiments. Similarly, the lateral recesses may have an aspect ratio, or a ratio of their depth extending laterally to their height expanding vertically, greater than or about 2, greater than or about 5, greater than or about 10, greater than or about 20, greater than or about 30, greater than or about 50, or more in embodiments. In some embodiments, a liner material may be formed along the trench or recess sidewalls to protect the substrate from metal diffusion.


The operations of method 400 will now be described in conjunction with the schematic illustration of FIGS. 5A-5D. FIG. 5A illustrates a portion of a processed structure 500a. The processed structure 500a may be produced during a multi-patterning process. The processed structure 500a may be further developed in producing, for example, FinFET structures, or any other semiconductor structures. The processed structure 500a may include layered materials and features overlaying a substrate 505. For example, the processed structure may include a patterned structure 510 sandwiched between adjacent hard mask spacers 515. Although only one patterned structure 510 and two adjacent hard spacers 515 are shown in FIG. 5A, the processed structure 500a may include more than one patterned structure 510 each of which may be sandwiched between two hard mask spacers 515. The patterned structure 510 may include a semiconductor material, such as silicon, germanium, silicon germanium, or may include a metal or metal-containing material, such as molybdenum. The hard mask spacer 515 may include a nitride, such as silicon nitride, a carbide, such as silicon carbide, an oxide, such as a thermal oxide or low temperature oxide which may include silicon oxide or other oxide that may be used or useful in semiconductor processes.


The patterned structure 510 may further include one or more layered materials above which the patterned structure 510 and the hard mask spacer 515 may be formed. The processed structure 500a may include a first layer 520 above which the patterned structure 510 and the hard mask spacer 515 may be formed. The first layer 520 may include another hard mask material, which may be the same as or different from the material of the hard mask spacers 515. The first layer 520 may include a nitride, such as silicon nitride, a carbide, such as silicon carbide, an oxide, such as a thermal oxide or low temperature oxide which may include silicon oxide or other oxide, and so on. The processed structure 500a may further include a second layer 525 below the first layer 520 and above the substrate 505. The second layer 525 may include another semiconductor material, which may be the same as or different from the material of the patterned structure 510. The second layer 525 may include silicon, germanium, silicon germanium, or molybdenum. In some embodiments, the first layer 520 may be formed by performing an oxidation process on the second layer 525. Accordingly, the first layer 520 may include an oxide layer of the material of the second layer 525. For example, the second layer 525 may include silicon, and the first layer 520 may include silicon oxide. Although the first layer 520 and the second layer 525 are described herein as examples, the processed structure 500a may include only one or more than two layers between the patterned structure 510 and the substrate 505.


In some embodiments, the processed structure 500a may be produced in the same processing chamber as the processing chamber in which method 400 may be performed, or may be produced in a different processing chamber and then transferred to the processing chamber in which method 400 may be performed. Once the substrate 505 may be positioned within a processing region of a semiconductor processing chamber, such as the substrate processing region 233 of the processing chamber 200 discussed above with reference to FIG. 2A, method 400 may be initiated by flowing a halogen-containing precursor into the processing region at operation 405. Method 400 may further include, at operation 410, contacting exposed regions of the processed structure 500a, which may include exposed regions of the semiconductor materials forming the patterned structure 510 and exposed regions of nitride, carbide, or oxide forming the hard mask spacers 515 and the first layer 520, with the halogen-containing precursor. During this operation, the halogen-containing precursor may be adsorbed at the surfaces of the exposed regions of the processed structure 500a. Method 400 may further include forming a film of the halogen-containing precursor at the exposed regions of the processed structure 500a at operation 415. As will be described in more detail below, the thickness of the halogen-containing precursor film formed at the exposed surfaces of the processed structure 500a may be controlled such that a predetermined thickness, including an atomic layer, a molecular layer, a few atomic layers, or a few molecular layers in some embodiments, of the halogen-containing precursor film may be obtained, which in turn may lead to controlled etching, such as atomic layer etching or molecular layer etching, of the exposed regions of the processed structure 500a.


The halogen-containing precursor may include a variety of fluids, and may include one or more of noble gas compound precursors, interhalogen precursors, fluorinating precursors, or other halogen-containing precursors that may be used or useful in semiconductor processes. The noble gas compound precursors may include one or more noble gas halides, which may include xenon halides, such as xenon fluoride, krypton halides, such as krypton fluoride, or any other compounds including a noble gas element and a halogen that may be used or useful in semiconductor processes.


One exemplary noble gas compound precursor may include xenon difluoride (XeF2). Xenon difluoride may include a vapor pressure of about 4 Torr at about 25° C. As mentioned above, the halogen-containing precursor film formed on the exposed surfaces of the processed structure 500a may be formed to a predetermined thickness, and in some embodiments, the film formed may include an atomic layer, a molecular layer, a few atomic layers, or a few molecular layers of the halogen-containing precursor. To achieve such predetermined thickness, xenon difluoride vapor or gas may be formed in a loading chamber before being flowed into the processing region of the processing chamber where the processed structure 500a may be positioned. To vaporize xenon difluoride, the pressure of the loading chamber may be maintained at about 4 Torr, and the temperature of the loading chamber may be maintained at about 25° C. The pressure and/or temperature of the loading chamber may be maintained at other suitable ranges, although the pressure may be maintained within a relatively low range to facilitate controlled flow of the xenon difluoride vapor or gas into the processing chamber where the processed structure 500a may be positioned, and the temperature may be maintained to be similar to the temperature at which method 400 may be performed.


For example, the pressure of the loading chamber may be maintained below or about 20 Torr in embodiments. The pressure of the loading chamber may be maintained below or about 15 Torr, and may be maintained below or about 10 Torr, below or about 5 Torr, below or about 4 Torr, below or about 3 Torr, below or about 2 Torr, below or about 1 Torr, below or about 500 mTorr, below or about 100 mTorr, below or about 50 mTorr, below or about 20 mTorr, below or about 10 mTorr, below or about 5 mTorr, below or about 4 mTorr, below or about 3 mTorr, below or about 2 mTorr, below or about 1 mTorr, or lower. In embodiments the pressure may be maintained between about 500 mTorr and about 10 Torr. In embodiments the pressure may be maintained below about 500 mTorr. The temperature of the loading chamber may be maintained between about 0° C. and about 50° C. in embodiments. The temperature may be maintained above or about 5° C., and may be maintained above or about 10° C., above or about 15° C., above or about 20° C., above or about 25° C., above or about 30° C., above or about 35° C., above or about 40° C., above or about 45° C., above or about 50° C., or higher. When xenon difluoride gas may not be included or flowed into the processing chamber, the pressure of the loading chamber may be maintained at an increased level, and/or the temperature of the loading chamber may be maintained at a decreased level such that xenon difluoride may be preserved in the loading chamber in a solid form.


Once vaporized in the loading chamber, the xenon difluoride vapor or gas may then be flowed into the processing region of the processing chamber where the processed structure 500a may be positioned via a gas distribution assembly of the processing chamber, such as the gas distribution assembly 205 of the processing chamber 200 described above with reference to FIG. 2 at operation 405. The xenon difluoride gas may also be flowed through one or more faceplates and/or showerheads, such as the faceplate 217 and the showerhead 225 described above with reference to FIG. 2, to facilitate even distribution of the precursor onto the processed structure 500a. At operation 410, the xenon difluoride gas may then contact the exposed regions of the processed structure 500a, and may form a film on the exposed surfaces of the processed structure 500a at operation 415. Although a loading chamber is described herein as an example for delivery of xenon difluoride, xenon difluoride, as well as other halogen-containing precursors, may be generated in situ in some embodiments of the technology, as will be described in more detail below.


The interhalogen precursors may include one or more compounds containing two or more halogen elements, such as one or more fluorides containing fluorine and one or more of chlorine, bromine, or iodine, one or more chlorides containing chlorine and one or more of fluorine, bromine, or iodine, one or more bromides containing bromine and one or more of fluorine, chlorine, or iodine, or other interhalogen precursors that may be used or useful in semiconductor processes. Some exemplary interhalogen precursors may include iodine fluoride, such as iodine monofluoride, iodine trifluoride, iodine pentafluoride, iodine heptafluoride, and may further include chlorine fluoride, such as chlorine monofluoride, chlorine trifluoride, chlorine pentafluoride, and so on. As compared to diatomic halogens, interhalogen compounds may be more reactive and thus serve better halogenating agents because the interhalogen bonds may be weaker as compared to diatomic halogen bonds, except for F2. The highly reactive interhalogen compounds may be used as halogen-containing precursors for selective etching of semiconductor or other materials used in semiconductor processes and device manufacturing. During the etching process, the element of the interhalogen having a relatively higher electronegativity, such as fluorine, may react with the materials to be etched to form volatile etching byproducts, and the element of the interhalogen having a relatively lower electronegativity may be recycled to re-form one or more halogen-containing precursors using a plasma process, as will be described in more detail below.


The fluorinating precursors may include any of the noble gas compound precursors or the interhalogen precursors described above, or other fluorinating precursors that may be used or useful in selective etching of semiconductor or other materials used in semiconductor processes and device manufacturing.


To achieve the predetermined thickness, such an atomic layer, a molecular layer, a few atomic layers, or a few molecular layers, of the xenon difluoride film or other halogen-containing precursor film formed on the exposed surfaces of the processed structure 500a, the amount or dosage of xenon difluoride or other halogen-containing precursors delivered to the processing region of the processing chamber where the processed structure 500a may be positioned may be controlled. For example, the amount or dosage of the xenon difluoride gas or other halogen-containing precursors that may be flowed into the processing region may be predetermined or calculated based on desired film thickness, the flow rate at which xenon difluoride or other halogen-containing precursors may be flowed, the amount of time during which xenon difluoride or other halogen-containing precursors may be flowed, the pressure of the processing region, the temperature of the processing region and/or the processed structure 500a, the particular structures and features of the processed structure 500a, and so on.


In some embodiments, a precursor delivery system incorporating one or more precision valves may be utilized to facilitate the controlled delivery of the halogen-containing precursors. With reference to FIG. 6, an exemplary precursor delivery system 600 may include a loading chamber 602, such as the loading chamber discussed above for forming vaporized xenon difluoride precursor. In some embodiments, the loading chamber 602 may also be configured to contain any other halogen-containing precursors described herein. In some embodiments, the loading chamber 602 may include or may employ a bubbler for facilitating delivery of xenon difluoride or other halogen-containing precursors. To control the amount or dosage of the halogen-containing precursors flowed from the loading chamber 602 to the processing chamber 604 within which the processed structure 500a may be positioned, and which may be representative of any of the previously described chambers, a precision valve 606 may be coupled to an outlet line of the loading chamber 602. In some embodiments, the precision valve 606 may include one or more atomic layer deposition valves. The atomic layer deposition valves may include high-speed pneumatic valves. The high-speed pneumatic valves may be opened for a period of time that may be less than or about a few seconds in embodiments, and may be opened for less than or about 1 second, less than or about 0.5 seconds, less than or about 0.1 seconds, less than or about 50 milliseconds, less than or about 40 milliseconds, less than or about 30 milliseconds, less than or about 20 milliseconds, less than or about 10 milliseconds, less than or about 5 milliseconds, less than or about 4 milliseconds, less than or about 3 milliseconds, less than or about 2 milliseconds, less than or about 1 millisecond, or less. In some embodiments, before being flowed into the processing chamber 604, the halogen-containing precursors may be mixed or combined with one or more carrier gases. For example, when the precision valve 606 may be opened, the halogen-containing precursors may be flowed into a carrier gas line 608. Through the carrier gas line 608, the carrier gases may be flowed and may carry the halogen-containing precursors to the processing chamber 604. The flow of the carrier gases may be controlled through one or more mass-flow controllers 612.


The flow rate and/or amount of the halogen-containing precursors flowed into the processing chamber 604 may be controlled in a variety of ways. In some embodiments, the precision valve 606 may be opened for a predetermined period of time to control the halogen-containing precursors flowed into the carrier gas line 608. For example, the precision valve 606 may be opened for a period of time less than or about 1 second, less than or about 0.5 seconds, less than or about 0.1 seconds, less than or about 50 milliseconds, less than or about 40 milliseconds, less than or about 30 milliseconds, less than or about 20 milliseconds, less than or about 10 milliseconds, less than or about 5 milliseconds, less than or about 4 milliseconds, less than or about 3 milliseconds, less than or about 2 milliseconds, less than or about 1 millisecond, or less, depending on the specific application or process may require. In some embodiments, the flow rate and/or amount of the halogen-containing precursors flowed into the processing chamber 604 may also be controlled by adjusting the flow of the carrier gases to obtain a desired dilution factor. In some embodiments, a ratio of the flow rate of the carrier gases to the flow rate of the halogen-containing precursors before combining may be greater than or about 5:1, greater than or about 10:1, greater than or about 20:1, greater than or about 50:1, greater than or about 100:1, greater than or about 200:1, greater than or about 300:1, greater than or about 400:1, greater than or about 500:1, or more. By controlling the period of time the precision valve 606 may be opened and/or the dilution of the halogen-containing precursors by the carrier gases, the amount or dosage of the halogen-containing precursors delivered to the processing chamber 604 may be controlled to obtain desired etching rates.


Depending on the specific applications, in some embodiments, the flow rate of xenon difluoride or other halogen-containing precursors may be less than or about 50 sccm in embodiments, and may be less than or about 45 sccm, less than or about 40 sccm, less than or about 35 sccm, less than or about 30 sccm, less than or about 25 sccm, less than or about 20 sccm, less than or about 15 sccm, less than or about 10 sccm, less than or about 5 sccm, less than or about 3 sccm, less than or about 1 sccm, or less. The flow rate of the xenon difluoride gas or other halogen-containing precursors may be maintained at a relatively low level to facilitate dosage control as well as to improve the uniformity of the thickness of the film formed at the exposed surfaces of the processed structure 500a.


Additionally, the flow or delivery of xenon difluoride or other halogen-containing precursors may be pulsed for time periods of less than or about 30 seconds in embodiments, and may be pulsed for time periods of less than or about 25 seconds, less than or about 20 seconds, less than or about 15 seconds, less than or about 10 seconds, less than or about 5 seconds, less than or about 2 seconds, or less. Between each of the pulsed flow or delivery, the flow or delivery of xenon difluoride or other halogen-containing precursors may be paused for less than or about 30 seconds in embodiments, and may be paused for time periods of less than or about 25 seconds, less than or about 20 seconds, less than or about 15 seconds, less than or about 10 seconds, less than or about 5 seconds, less than or about 2 seconds, or less. Additionally, the flow rate and pulsing may be combined for any of the listed numbers. For example, the flow rate of xenon difluoride or other halogen-containing precursors may be below or about 10 sccm and may be delivered in pulses from about 5 to about 10 seconds in embodiments, depending on the desired thickness of the film formed.


In some embodiments, the pressure of the processing region may be maintained below or about 50 Torr in embodiments. The pressure may be maintained below or about 40 Torr, and may be maintained below or about 30 Torr, below or about 20 Torr, below or about 15 Torr, below or about 10 Torr, below or about 5 Torr, below or about 4 Torr, below or about 3 Torr, below or about 2 Torr, below or about 1 Torr, below or about 800 mTorr, below or about 600 mTorr, below or about 400 mTorr, below or about 200 mTorr, below or about 100 mTorr, below or about 80 mTorr, below or about 60 mTorr, below or about 40 mTorr, below or about 20 mTorr, below or about 10 mTorr, below or about 5 mTorr, below or about 2 mTorr, below or about 1 mTorr, or lower. Maintaining a relatively low pressure inside the processing chamber may facilitate even adsorption and uniform film formation by the halogen-containing precursors at the surfaces of the processed structure 500a, and in some embodiments, to facilitate atomic or molecular layer adsorption of xenon difluoride or other halogen-containing precursors at the exposed surfaces.


In some embodiments, the temperature of the processing region or at the substrate level may be maintained between about 0° C. and about 100° C. in embodiments. The temperature may be maintained above or about 5° C., and may be maintained above or about 10° C., above or about 15° C., above or about 20° C., above or about 25° C., above or about 30° C., above or about 35° C., above or about 40° C., above or about 45° C., above or about 50° C., above or about 60° C., above or about 70° C., above or about 80° C., above or about 90° C., or higher. In some embodiments, the temperature of the processing region or at the substrate level may be maintained at about room temperature or the chamber temperature without additional heating or cooling performed at the substrate level. The room temperature may range between about 10° C. and about 50° C.


By controlling the flow of the halogen-containing precursors, the temperature and/or pressure of the loading chamber of the halogen-containing precursors (if utilized), the temperature and/or pressure of the processing region of the chamber where the processed structure 500a may be positioned, and/or other operational parameters, a film of the halogen-containing precursors with a desired thickness, including atomic-layer thickness, and uniformity may be formed at the exposed regions of the processed structure 500a. As mentioned above, controlled film formation of the halogen-containing precursors at the exposed regions of the processed structure 500a may further lead to controlled etching, including atomic or molecular layer etching in some embodiments, of the exposed regions of the processed structure 500a. In some embodiments, method 400 may also include pausing the flow of the halogen-containing precursors at operation 420 by halting the flow of the halogen-containing precursors, and may further include purging the halogen-containing precursors that may not be adsorbed on the exposed surfaces of the processed structure 500a at operation 425 using one or more inert gases. In some embodiments, the purging operation 425 may be performed immediately after the predetermined amount of the halogen-containing precursors may be flowed. In some embodiments, the purging operation 425 may be performed after the flow of the halogen-containing precursors may be paused for a period of time so as to allow the halogen-containing precursors to flow onto and to be adsorbed on the exposed surfaces of the processed structure 500a. For example, the purging operation 425 may be performed after the flow of the halogen-containing precursors may be paused for a time period of less than or about 30 seconds in embodiments, and may be paused for time periods of less than or about 25 seconds, less than or about 20 seconds, less than or about 15 seconds, less than or about 10 seconds, less than or about 5 seconds, less than or about 2 seconds, or less.


By performing these operations 420, 425, only the halogen-containing precursors that may be adsorbed at the exposed surfaces of the processed structure 500a may remain in the processing region forming the halogen-containing precursor film of the predetermined thickness, and any excess may be removed from the processing region. Method 400 may then proceed to operation 430 to etch the exposed regions of the processed structure 500a with the adsorbed halogen-containing precursors. Because the thickness of the halogen-containing precursor film may be predetermined, or in other words, the amount of the halogen-containing precursors available for the etching operation 430 may be predetermined, the thickness or amount of the materials etched may be controlled at operation 430. In some embodiments, when one or a few atomic or molecular layers of the halogen-containing precursors may be adsorbed at the exposed surfaces of the processed structure 500a after performing operations 405-425, atomic or molecular layer etching of select materials (discussed further below) at the exposed regions of the processed structure 500a may be achieved in operation 430.


In some embodiments, depending on the thickness or amount of the halogen-containing precursors adsorbed, a thickness of less than or about 5 nm of select materials at the exposed regions of the processed structure 500a may be etched or removed. In some embodiments, an etching or removal thickness of less than or about 4 nm, less than or about 3 nm, less than or about 2 nm, less than or about 1 nm, less than or about 9 Å, less than or about 8 Å, less than or about 7 Å, less than or about 6 Å, less than or about 5 Å, less than or about 4 Å, less than or about 3 Å, less than or about 2 Å, or less in embodiments. In some embodiments, the removal may be at least about 5 Å, and may be between about 5 Å and about 5 nm of removal, or between about 10 Å and about 2 nm of removal. In some embodiments, method 400 may be repeated for several cycles to achieve a greater overall removal thickness. In some embodiments, method 400 may be repeated for at least two cycles, and may be repeated for at least about 3 cycles, at least about 5 cycles, at least about 8 cycles, at least about 10 cycles, at least about 20 cycles, at least about 50 cycles, at least about 100 cycles, or more. The number of cycles may be dependent on the amount of removal provided by each cycle. By performing method 400 in cycles and removing only a controlled amount, including in some embodiments, one or a few atomic or molecular layers, of the materials to be etched, a uniform or smooth etching profile may be obtained.


As mentioned previously, not all exposed regions of the processed structure 500a may be etched by the halogen-containing precursors, and only select materials may be etched, depending on the operational parameters of the processing region and the materials at the exposed regions of the processed structure 500a. In the example as shown in FIG. 5A, during operation 430, the halogen-containing precursors may interact with the patterned structure 510, which may include one or more semiconductor materials, such as silicon, germanium, silicon germanium, or may include a metal or metal-containing, such as molybdenum. There may be substantially no or very limited interaction between the halogen-containing precursors and the hard mask spacers 515 or the first layer 520, which may include one or more of a nitride, a carbide, or an oxide, such as silicon nitride, silicon carbide, or silicon oxide. At about room temperature, the halogen-containing precursors may have a selectivity toward the semiconductor material forming the patterned structure 510 to the nitride, carbide, or oxide material forming the hard mask spacers 515 or the first layer 520 greater than or about 100:1, greater than or about 200:1, greater than or about 300:1, greater than or about 400:1, or higher depending on the operating conditions.


The interaction between the adsorbed halogen-containing precursors with the exposed semiconductor material of the patterned structure 510 may produce one or more volatile substances, which may then be removed from the processing chamber. The volatile byproducts produced by the interaction between the halogen-containing precursors and the semiconductor material may include a halide of the semiconductor material, such as a fluoride of the semiconductor material, which may include silicon fluoride, such as silicon tetrafluoride, germanium fluoride, such as germanium tetrafluoride, molybdenum fluoride, such as molybdenum hexafluoride, or any fluorinated compound or molecule of the etched material. The volatile byproducts produced may further include a noble gas or a halogen, depending on the halogen-containing precursors flowed. For example, when a noble gas halide, such as xenon difluoride, may be used as one of the halogen-containing precursors, xenon gas may be released and may be removed from the chamber. When an interhalogen, such as chlorine fluoride, may be used as one of the halogen-containing precursors, chlorine gas may be released and may be removed from the chamber. As will be described in more detail below, the noble gas or halogen released may be captured and recycled to produce additional halogen-containing precursors.


Although not shown in FIG. 5A, the processed structure 500a may further include exposed regions of one or more metal-containing materials. In some embodiments, the metal-containing materials may include titanium, tantalum, tungsten, or one or more compounds thereof, such as titanium nitride, tantalum nitride, titanium tungsten, and so on. The halogen-containing precursors substantially may not interact with or may interact only to a limited extent with these metal-containing materials at about room temperature, although the halogen-containing precursors may interact and thus etch these metal-containing materials at elevated temperatures as will be discussed in more detail below. At about room temperature, the halogen-containing precursors may have a selectivity towards the semiconductor material forming the patterned structure 510 over titanium, titanium nitride, tantalum, tantalum nitride, tungsten, or titanium tungsten of greater than or about 50:1, greater than or about 100:1, greater than or about 150:1, greater than or about 200:1, or higher depending on the operating conditions.


In some embodiments, the processed structure 500a may further include exposed regions of other metal-containing materials that the halogen-containing precursors substantially may not interact with or may only react to a limited extent at room or elevated temperatures. Such metal-containing materials may include gold, copper, aluminum, nickel, chrome, platinum, gallium, hafnium, and so on. In some embodiments, the halogen-containing precursors, such as xenon difluoride, may not interact with aluminum, nickel, chrome, platinum, gallium, hafnium or the interaction with these metals may be so limited that the selectivity toward the semiconductor material forming the patterned structure 510 to these metals may be close to infinite.


Other commonly used materials in semiconductor processing that the halogen-containing precursors may not interact with may further include aluminum nitride, gallium arsenide, select oxides, such as PZT, magnesium oxide, zinc oxide, hafnium oxide, titanium oxide, aluminum oxide, zirconium dioxide, and so on. The halogen-containing precursors may not interact with polymers or select organic compounds commonly used in semiconductor processing, such as photoresists, PDMS (polydimethylsiloxane), C4F8, silica glass, dicing tape, PP (polypropylene), PEN (polyethylene naphthalate), PET (polyethylene terephthalate), ETFE (ethylene tetrafluoroethylene), acrylic, and so on.


Because the halogen-containing precursors may have a high selectivity toward the semiconductor material forming the patterned structure 510 over the materials forming the hard mask spacers 515 and the first layer 520 as discussed above, by performing method 400 in one or more cycles, the processed structure 500a as shown in FIG. 5A may be developed into the processed structure 500b shown in FIG. 5B. In some embodiments, the processed structure 500b may be further processed into the processed structure 500c shown in FIG. 5C, with only the portions of the first layer 520 below the hard mask spacers 515 remaining, the hard mask spacers 515 and the portions of the first layer 520 not covered by the hard mask spacers 515 being removed. The processed structure 500c may be produced using deposition of mask layers combined with dry etching processes, which may be performed in the same processing chamber as method 400.


Once the processed structure 500c may be produced, method 400 may be initiated again or repeated to further develop the processed structure 500c into the processed structure 500d shown in FIG. 5D. Specifically, as discussed above, the first layer 520 may include a nitride, such as silicon nitride, a carbide, such as silicon carbide, an oxide, such as a thermal oxide or low temperature oxide which may include silicon oxide or other oxide, and so on, and the second layer 525 may include a semiconductor material, such as silicon, germanium, silicon germanium, or may include a metal or metal-containing material, such as molybdenum. As also discussed above, the halogen-containing precursors may have a high selectivity towards semiconductor materials, such as those included in the second layer 525 over the nitride, carbide, or oxide which may be included in the first layer 520. Therefore, when one or more halogen-containing precursors may be flowed into the processing region, the second layer 525 may be etched or removed by the halogen-containing precursors while the remaining portions of the first layer 520 may not be removed, and the processed structure 500d of FIG. 5D may be produced. The processed structure 500d may be produced by performing method 400 for one or more cycles, with each cycle removing a predetermined thickness of the second layer 525 material, and in some embodiments, with each cycle removing only one or a few atomic or molecular layers of the second layer 525 material.


There are several advantages of method 400. Because the halogen-containing precursors used in method 400 may have very high selectivity towards semiconductor materials over a wide variety of metals, oxide, nitride, or carbide commonly used in semiconductor processing, method 400 may be used for selective etching of semiconductor materials, such as silicon, germanium, silicon germanium, or may be used for selective etching of metal or metal-containing materials, such as molybdenum, using very thin mask materials. For example, as shown in FIGS. 5A and 5B, selective etching of the semiconductor material forming the patterned structure 510 may be achieved using very narrow masks or spacers, such as the hard mask spacers 515, which may be only a few nanometers or less. Similarly, as shown in FIGS. 5C and 5D, selective etching of the semiconductor material forming the second layer 525 may also be achieved using very thin masks, such as the first layer 520, which may be only a few nanometers, a few angstroms, or less. Additionally, by controlling the thickness of the halogen-containing precursors adsorbed on exposed regions of materials to be etched and by performing method 400 in cycles, atomic or molecular layer etching in each cycle may be achieved, and the uniformity of the etched profile may also be improved. Moreover, as can be understood from the description above, method 400 may be plasma free, which may avoid damage to the processed structure caused by plasma many conventional dry etching methods utilize.


Another advantage associated with method 400 may include isotropic etching of semiconductor materials, such as silicon, germanium, silicon germanium, or metal or metal-containing materials, such as molybdenum. Using silicon as an example, many etchants used in both wet and dry etching processes may only etch silicon at or from select crystal planes but not the others. For example, many etchants may not etch or may substantially stop etching when contacted with (110), (111), etc., crystal planes of silicon. As such, in the case of the substrate features formed of single-crystal silicon, the features may not be etched if the exposed surfaces correspond to one of the above mentioned crystal planes of silicon. In the case of the substrate features formed of polysilicon, the etched profile may not be uniform because depending on the orientation of the crystals, some may be etched while others may not be etched. In contrast, the halogen-containing precursors used in the present technology may etch the above mentioned semiconductor materials from any crystal planes or towards any crystal directions. Therefore, whether the substrate features may be formed of single- or polysilicon, the exposed surfaces may be etched uniformly. Further, because the halogen-containing precursors may etch the semiconductor materials from any crystal planes or towards any crystal directions, method 400 may be utilized in lateral recessing of semiconductor features, such as lateral recessing operations which may be performed in producing V-NAND memory cells.


With reference to FIG. 7 exemplary operations of another method 700 are shown according to embodiments of the present technology. Different from method 400, method 700 may be implemented for etching of select metal-containing materials, which may include titanium, tantalum, tungsten, or one or more compounds thereof, such as titanium nitride, tantalum nitride, titanium tungsten, and so on. Method 700 may include operations similar to operations of method 400 to achieve finely controlled delivery of etching precursors and to achieve thin layer etching, including atomic or molecular layer etching, of select materials.


Method 700 may include, at operation 705, flowing a halogen-containing precursor into a processing region of a processing chamber where a processed structure may be positioned. The halogen-containing precursors utilized for method 400 may also be utilized for method 700. Accordingly, the halogen-containing precursors flowed at operation 705 may include one or more of noble gas compound precursors, interhalogen precursors, fluorinating precursors, or other halogen-containing precursors. The noble gas compound precursors may include one or more noble gas halides, which may include xenon halides, such as xenon fluoride, krypton halides, such as krypton fluoride, or any other compounds including a noble gas element and a halogen that may be used or useful in semiconductor processes. Similar to method 400, method 700 may utilize xenon difluoride as one of the halogen-containing precursors, which may be vaporized first in a loading chamber, and then flowed to the processing region of the processing chamber where the processed structure to be etched may be positioned. During the operations of method 700, the pressure and/or temperature of the loading chamber may be maintained at similar levels to those maintained for the loading chamber described above with reference to operations of method 400. The interhalogen precursors may include one or more fluorides containing fluorine and one or more of chlorine, bromine, or iodine, one or more chlorides containing chlorine and one or more of fluorine, bromine, or iodine, one or more bromides containing bromine or one or more of fluorine, chlorine, or iodine, or other interhalogen precursors that may be used or useful in semiconductor processes. Some exemplary interhalogen precursors may include iodine fluoride, such as iodine monofluoride, iodine trifluoride, iodine pentafluoride, iodine heptafluoride, and may further include chlorine fluoride, such as chlorine monofluoride, chlorine trifluoride, chlorine pentafluoride, and so on. The fluorinating precursors may include any of the noble gas compound precursors or the interhalogen precursors described above.


Method 700 may further include operation 710 similar to operation 410, during which the halogen-containing precursors may contact the exposed regions of the processed structure, which may include exposed regions of select metal-containing materials, such as titanium, tantalum, tungsten, or one or more compounds thereof, such as titanium nitride, tantalum nitride, titanium tungsten, and so on. Method 700 may also forming a film on the surfaces of the exposed regions of the processed structure at operation 715, which may be similar to operation 415. Method 700 may also include pausing the flow of the halogen-containing precursors at operation 720 by halting the flow of the halogen-containing precursors, and may further include purging the halogen-containing precursors that may not be adsorbed on the exposed surfaces of the processed structure at operation 725 such that only the halogen-containing precursors that may be adsorbed at the exposed surfaces of the processed structure may remain in the processing region forming the halogen-containing precursor film, and any excess may be removed from the processing region. In some embodiments, only one or a few atomic or molecular layers of the halogen-containing precursors may be adsorbed on the exposed surfaces of the processed structure.


Similar to method 400, method 700 may include additional controls over operational conditions and such to control the thickness of the halogen-containing precursor film. For example, at operation 705, only a predetermined or calculated amount or dosage of the halogen-containing precursors may be flowed to the processing region. The flow rate of the halogen-containing precursors may be maintained at relatively low levels to facilitate uniform film formation. For example, the flow rate of the halogen-containing precursors may be less than or about 50 sccm in embodiments, and may be less than or about 45 sccm, less than or about 40 sccm, less than or about 35 sccm, less than or about 30 sccm, less than or about 25 sccm, less than or about 20 sccm, less than or about 15 sccm, less than or about 10 sccm, less than or about 5 sccm, less than or about 3 sccm, less than or about 1 sccm, or less. Additionally, the flow of the halogen-containing precursors may be pulsed for time periods of less than or about 30 seconds in embodiments, and may be pulsed for time periods of less than or about 25 seconds, less than or about 20 seconds, less than or about 15 seconds, less than or about 10 seconds, less than or about 5 seconds, less than or about 2 seconds, or less. Between each of the pulsed flow or delivery, the flow or delivery of the halogen-containing precursors may be paused for less than or about 30 seconds in embodiments, and may be paused for time periods of less than or about 25 seconds, less than or about 20 seconds, less than or about 15 seconds, less than or about 10 seconds, less than or about 5 seconds, less than or about 2 seconds, or less. The flow rate and pulsing may be combined for any of the listed numbers. For example, the flow rate of the halogen-containing precursors may be below or about 10 sccm and may be delivered in pulses from about 5 to about 10 seconds in embodiments, depending on the desired thickness of the film formed.


The pressure of the processing region of the processing chamber may be maintained at relatively low levels, similar to the pressure levels maintained during operations of method 400. In some embodiments, the pressure of the processing region may be maintained below or about 50 Torr in embodiments. The pressure may be maintained below or about 40 Torr, and may be maintained below or about 30 Torr, below or about 20 Torr, below or about 15 Torr, below or about 10 Torr, below or about 5 Torr, below or about 4 Torr, below or about 3 Torr, below or about 2 Torr, below or about 1 Torr, below or about 800 mTorr, below or about 600 mTorr, below or about 400 mTorr, below or about 200 mTorr, below or about 100 mTorr, below or about 80 mTorr, below or about 60 mTorr, below or about 40 mTorr, below or about 20 mTorr, below or about 10 mTorr, below or about 5 mTorr, below or about 2 mTorr, below or about 1 mTorr, or lower. Maintaining a relatively low pressure inside the processing chamber may facilitate even adsorption and uniform film formation by the halogen-containing precursors, and in some embodiments, to facilitate atomic or molecular layer adsorption of the halogen-containing precursors.


Although many operational conditions for method 700 may be kept to be similar to those for method 400, the temperature in the processing region or at the substrate level may be maintained at an elevated level during method 700 as compared to that of method 400 so as to allow for selective etching of titanium, tantalum, tungsten, or one or more compounds thereof, such as titanium nitride, tantalum nitride, titanium tungsten, and so on. In some embodiments, the temperature of the processing region or at the substrate level may be maintained between about 0° C. and about 400° C. in embodiments. The temperature may be maintained above or about 5° C., and may be maintained above or about 10° C., above or about 15° C., above or about 20° C., above or about 25° C., above or about 30° C., above or about 50° C., above or about 75° C., above or about 100° C., above or about 150° C., above or about 200° C., above or about 250° C., above or about 300° C., above or about 350° C., or higher. Maintaining the temperature of the processing region or the substrate at relatively high temperature may increase the etch rate of titanium, tantalum, tungsten, or one or more compounds thereof, such as titanium nitride, tantalum nitride, titanium tungsten. However, relatively high operational temperature may also decrease the selectivity of the halogen-containing precursors towards these materials. Depending on the particular application, the temperature of the processing region may be maintained between about room temperature and about 300° C. to achieve desired etch rate as well as desired selectivity.


Once a desired thickness of the halogen-containing precursor film may be adsorbed on the exposed regions of the processed structure, method 700 may then proceed to operation 730 to etch select materials at the exposed regions of the processed structure. The interaction between the adsorbed halogen-containing precursors with titanium, tantalum, tungsten, titanium nitride, tantalum nitride, or titanium tungsten may produce one or more volatile substances, which may then be removed from the processing chamber. The volatile byproducts produced may include halides of titanium, tantalum, or tungsten, such as fluorides of titanium, tantalum, or tungsten. The volatile byproducts produced may further include a noble gas or a halogen, which may be captured and recycled to produce additional halogen-containing precursors, as described below.


Depending on the thickness or amount of the halogen-containing precursors adsorbed, an etched thickness of less than or about 5 nm may be achieved. In some embodiments, an etching or removal thickness of less than or about 4 nm, less than or about 3 nm, less than or about 2 nm, less than or about 1 nm, less than or about 9 Å, less than or about 8 Å, less than or about 7 Å, less than or about 6 Å, less than or about 5 Å, less than or about 4 Å, less than or about 3 Å, less than or about 2 Å, or less in embodiments, down to a few molecules of removal may be achieved. In some embodiments, the removal may be at least about 5 Å, and may be between about 5 Å and about 5 nm of removal, or between about 10 Å and about 2 nm of removal. In some embodiments, method 700 may be repeated for several cycles to achieve a greater overall removal thickness. In some embodiments, method 700 may be repeated for at least two cycles, and may be repeated for at least about 3 cycles, at least about 5 cycles, at least about 8 cycles, at least about 10 cycles, at least about 20 cycles, at least about 50 cycles, at least about 100 cycles, or more. The number of cycles may be dependent on the amount of removal provided by each cycle.


Method 700 may have a selectivity towards titanium, tantalum, tungsten, titanium nitride, tantalum nitride, or titanium tungsten over silicon nitride, silicon carbide, silicon oxide, thermal oxide, or low temperature oxide of greater than or about 50:1, greater than or about 100:1, greater than or about 150:1, greater than or about 200:1, or higher depending on the operating conditions. Method 700 may also have a similar selectivity towards titanium, tantalum, tungsten, titanium nitride, tantalum nitride, or titanium tungsten over gold or copper. Other materials commonly used in semiconductor processing that method 700 may not etch, or may have a close to infinite selectivity over, even at elevated temperatures may include aluminum, nickel, chrome, platinum, gallium, hafnium, aluminum nitride, gallium arsenide, select oxides, such as PZT, magnesium oxide, zinc oxide, hafnium oxide, titanium oxide, aluminum oxide, zirconium dioxide, and so on. Method 700 may further have high selectivity over select polymers or organic compounds commonly used in semiconductor processing, such as photoresists, PDMS (polydimethylsiloxane), C4F8, silica glass, dicing tape, PP (polypropylene), PEN (polyethylene naphthalate), PET (polyethylene terephthalate), ETFE (ethylene tetrafluoroethylene), acrylic, and so on.


It should be noted that although method 400 and method 700 are described as separate methods, method 700 may also be performed to etch or remove the semiconductor materials that method 400 may be performed to etch or remove. Given the elevated temperature, method 700 may yield greater etch rates as compared to method 400. However, method 400 may yield improved selectivity. Depending on the particular application, if the structure to be processed containing exposed regions of materials may be etched by both method 400 and method 700, then method 700 may be performed. For example, if the materials to be removed include one of the metal-containing materials etched by method 700, such as titanium, titanium nitride, tantalum, tantalum nitride, tungsten, or titanium tungsten, in addition to the semiconductor materials etched by method 400, such as silicon, germanium, or silicon germanium, or the metal-containing materials etched by method 400, such as molybdenum, then method 700 may be performed to remove the semiconductor materials as well as the metal-containing materials. If in some embodiments, the semiconductor materials or the metal-containing materials may be removed at different operations, then the temperature in the processing region or at the substrate level may be adjusted accordingly to achieve desired removal using either method 400 or method 700. Alternatively, the substrate may be processed at different processing chambers maintained at different temperatures, with one at room temperature for method 400 and one at elevated temperature for method 700.


With reference to FIG. 8, exemplary operations of another method 800 are shown according to embodiments of the present technology. Method 800 may include operations 805-830 similar to or the same as operations 405-430 of method 400 or operations 705-730 of method 700, depending on the particular materials to be removed. In some embodiments, operations 805-830 may be similar to operations 405-430 for etching semiconductor materials. In some embodiments, operations 805-830 may be similar to operations 705-730 for etching select metal-containing materials and/or semiconductor materials.


Method 800 may include, at operation 805, flowing a first halogen-containing precursor into a processing region of a processing chamber where a processed structure may be positioned. The first halogen-containing precursor may include one or more of any of the halogen-containing precursors described above with reference to method 400 and method 700. Accordingly, the first halogen-containing precursor flowed at operation 805 may include one or more of noble gas compound precursors, interhalogen precursors, fluorinating precursors, or other halogen-containing precursors. The noble gas compound precursors may include one or more noble gas halide, which may include xenon halides, such as xenon fluoride, krypton halides, such as krypton fluoride, or any other compounds including a noble gas element and a halogen that may be used or useful in semiconductor processes. Similar to method 400 and method 700, method 800 may utilize xenon difluoride as the first halogen-containing precursor. The interhalogen precursors may include one or more fluorides containing fluorine and one or more of chlorine, bromine, or iodine, one or more chlorides containing chlorine and one or more of fluorine, bromine, or iodine, one or more bromides containing bromine or one or more of fluorine, chlorine, or iodine, or other interhalogen precursors that may be used or useful in semiconductor processes. Some exemplary interhalogen precursors may include iodine fluoride, such as iodine monofluoride, iodine trifluoride, iodine pentafluoride, iodine heptafluoride, and may further include chlorine fluoride, such as chlorine monofluoride, chlorine trifluoride, chlorine pentafluoride, and so on. The fluorinating precursors may include any of the noble gas compound precursors or the interhalogen precursors described above.


Method 800 may further include operation 810, during which the first halogen-containing precursor may contact the exposed regions of the processed structure, and may form a film on the exposed surfaces of the processed structure at operation 815. Method 800 may also include pausing the flow of the first halogen-containing precursor at operation 820 by halting the flow of the first halogen-containing precursor, and may further include purging the first halogen-containing precursor that may not be adsorbed on the exposed surfaces of the processed structure at operation 825 such that only the first halogen-containing precursor that may be adsorbed at the exposed surfaces of the processed structure may remain in the processing region forming the first halogen-containing precursor film, and any excess may be removed from the processing region. In some embodiments, only one or a few atomic or molecular layers of the first halogen-containing precursor may be adsorbed on the exposed surfaces of the processed structure. Similar to method 400 and method 700, method 800 may further implement controls over the flow rate of the first halogen-containing precursor, the temperature and/or pressure of the loading chamber of the first halogen-containing precursor (if utilized), the temperature and/or pressure of the processing region of the chamber where the processed structure may be positioned, and/or other operational parameters, to obtain a desired thickness of the film of the first halogen-containing precursor, which may be one or a few atomic or molecular layers of the first halogen-containing precursor in some embodiments. Once the desired thickness of the first halogen-containing precursor film may be formed, method 800 may then proceed to operation 830 to etch select materials at the exposed regions of the processed structure, which may produce one or more volatile etch byproducts.


As mentioned above, certain etch byproducts may be collected and recycled to generate halogen-containing precursors. In some embodiments, a noble gas compound precursor may be used during operations 805-830, then one of the volatile byproducts generated may include a noble gas, which may be collected at operation 835. For example, when xenon difluoride may be used as the first halogen-containing precursor during operation 805-830, xenon gas may be produced at operation 830 and may be collected at operation 835. In some embodiments, an interhalogen precursor may be used during operations 805-830, then one of the volatile byproducts generated may include a gas of one of the halogen elements forming the interhalogen, such as the element having a relatively lower electronegativity compared to the other element forming the interhalogen. The gas of the halogen element having the relatively low electronegativity may also be collected at operation 835. For example, when a chlorine fluoride may be used at the first halogen-containing precursor during operation 805-830, chlorine gas may be produced at operation 830 and may be collected at operation 835.


The noble gas and/or the halogen gas collected at operation 835 may be delivered into a processing chamber or system at operation 840 to mix with a halogen-containing plasma, such as fluorine-containing plasma, which may include a plasma formed from nitrogen trifluoride. At operation 845, a second halogen-containing precursor may be formed through the reaction between the collected gas and the halogen-containing precursor. At operation 850, the second halogen-containing precursor may then be flowed back to the processing region for etching exposed regions of the processed structure, similar to how the first halogen-containing precursor may be flowed to the processing region for etching the exposed regions of the processed structure in operations 805-830. In some embodiments, the second halogen-containing precursor may be flowed back to the same processing region for continued etching of the processed structure. In some embodiments, the second halogen-containing precursor may be flowed to a different processing chamber for etching a different processed structure. In some embodiments, the second halogen-containing precursor generated may be preserved for later use. In the case of xenon difluoride, the xenon difluoride generated at step 845 may be collected by increasing the chamber pressure and/or lowering the chamber temperature such that xenon difluoride solid may be formed and collected. By collecting the noble gas or the halogen gas and generating additional halogen-containing precursor therefrom, method 800 may be more economical than conventional etching methods where byproducts may simply be discharged.


In some embodiments, the processing chamber for generating the second halogen-containing precursor may be the same as the processing chamber in which operations 805-830 may be performed. The processing chamber may include a remote plasma region, such as the capacitively-coupled plasma (CCP) region 215 described above with reference to FIG. 2, which may be fluidly connected with but separate from the processing region where the processed structure may be positioned. The plasma powers utilized may be relative low so as to prevent damage to structures on the processed structure. The plasma power in the CCP region may be at least about 50 W, and may be greater than or about 100 W, greater than or about 150 W, greater than or about 200 W, greater than or about 250 W, greater than or about 300 W, greater than or about 350 W, greater than or about 400 W, greater than or about 450 W, greater than or about 500 W, or more in embodiments.


In some embodiments, the processing chamber for generating the second halogen-containing precursor using plasma may be a different chamber separated from but fluidly connected with the processing chamber in which operations 805-830 may be performed. In some embodiments, the second halogen-containing precursor may be generated using a remote plasma system, such as the RPS 201 discussed above with reference to FIG. 2. When using a separate chamber or system for forming the second halogen-containing precursor, the plasma power utilized by the separate chamber or system may be at least about 500 W, and may be greater than or about 1000 W, greater than or about 1500 W, greater than or about 2000 W, greater than or about 2500 W, greater than or about 3000 W, greater than or about 3500 W, greater than or about 4000 W, or more, to facilitate the dissociation of the fluorine-containing precursors.


Generating the second halogen-containing precursor using a separate chamber or system may limit or prevent any plasma that may be flowed into the processing region, which may damage the substrate features and cause unevenness in the etched profile. It may also allow for more precise control of the halogen-containing precursor flowed towards the processed structure so as to achieve thin layer etching, such as atomic or molecular layer etching. In addition, because plasma may be used in forming the second halogen-containing precursor, the temperature of the second halogen-containing precursor formed may be relatively high. Forming the second halogen-containing precursor in a separate chamber or system may also allow the second halogen-containing precursor to be cooled to a desired temperature before being flowed to the processing region at operation 850.


In the preceding description, for the purposes of explanation, numerous details have been set forth in order to provide an understanding of various embodiments of the present technology. It will be apparent to one skilled in the art, however, that certain embodiments may be practiced without some of these details, or with additional details.


Having disclosed several embodiments, it will be recognized by those of skill in the art that various modifications, alternative constructions, and equivalents may be used without departing from the spirit of the embodiments. Additionally, a number of well-known processes and elements have not been described in order to avoid unnecessarily obscuring the present technology. Accordingly, the above description should not be taken as limiting the scope of the technology. Additionally, methods or processes may be described as sequential or in steps, but it is to be understood that the operations may be performed concurrently, or in different orders than listed.


Where a range of values is provided, it is understood that each intervening value, to the smallest fraction of the unit of the lower limit, unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Any narrower range between any stated values or unstated intervening values in a stated range and any other stated or intervening value in that stated range is encompassed. The upper and lower limits of those smaller ranges may independently be included or excluded in the range, and each range where either, neither, or both limits are included in the smaller ranges is also encompassed within the technology, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included.


As used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise. Thus, for example, reference to “a precursor” includes a plurality of such precursors, and reference to “the layer” includes reference to one or more layers and equivalents thereof known to those skilled in the art, and so forth.


Also, the words “comprise(s)”, “comprising”, “contain(s)”, “containing”, “include(s)”, and “including”, when used in this specification and in the following claims, are intended to specify the presence of stated features, integers, components, or operations, but they do not preclude the presence or addition of one or more other features, integers, components, operations, acts, or groups.

Claims
  • 1. An etching method comprising: flowing a halogen-containing precursor into a processing region of a semiconductor processing chamber;contacting an exposed region of a semiconductor material with the halogen-containing precursor such that the halogen-containing precursor is adsorbed on a surface of the exposed region of the semiconductor material;forming a film of the halogen-containing precursor of a predetermined thickness on the surface of the exposed region of the semiconductor material;pausing the flow of the halogen-containing precursor into the processing region of the semiconductor processing chamber; andetching the exposed region of the semiconductor material with the adsorbed halogen-containing precursor, wherein the adsorbed halogen-containing precursor produces a fluoride of the semiconductor material.
  • 2. The etching method of claim 1, further comprising purging the halogen-containing precursor not adsorbed on the surface of the exposed region of the semiconductor material.
  • 3. The etching method of claim 1, wherein the film of the halogen-containing precursor formed on the surface of the exposed region of the semiconductor material comprises an atomic layer of the halogen-containing precursor.
  • 4. The etching method of claim 1, wherein etching the exposed region of the semiconductor material comprises etching isotropically the exposed region of the semiconductor material.
  • 5. The etching method of claim 1, wherein the adsorbed halogen-containing precursor further produces a noble gas.
  • 6. The etching method of claim 1, wherein the halogen-containing precursor comprises at least one of a noble gas compound precursor, an interhalogen precursor, or a fluorinating precursor.
  • 7. The etching method of claim 1, wherein the semiconductor material comprises at least one of silicon, germanium, or a compound thereof.
  • 8. The etching method of claim 1, wherein a temperature of the semiconductor material is maintained at about room temperature.
  • 9. The etching method of claim 1, wherein the etching method is repeated for at least two cycles, and wherein a thickness of the semiconductor material etched during each cycle is between about 5 Å and about 50 Å.
  • 10. The etching method of claim 1, wherein the etching method has a selectivity toward the semiconductor material to a metal-containing material greater than or about 50:1, and wherein the metal-containing material comprises at least one of titanium, titanium nitride, tantalum, tantalum nitride, tungsten, or titanium tungsten.
  • 11. The etching method of claim 1, wherein a pressure within the semiconductor processing chamber is maintained between about 5 mTorr and about 50 Torr.
  • 12. An etching method comprising: flowing a halogen-containing precursor into a processing region of a semiconductor processing chamber;contacting an exposed region of a metal-containing material with the halogen-containing precursor such that the halogen-containing precursor is adsorbed on a surface of the exposed region of the metal-containing material;forming a film of the halogen-containing precursor on the surface of the exposed region of the metal-containing material;pausing the flow of the halogen-containing precursor into the processing region of the semiconductor processing chamber; andetching the exposed region of the metal-containing material with the adsorbed halogen-containing precursor, wherein the adsorbed halogen-containing precursor produces a fluoride of the metal-containing material.
  • 13. The etching method of claim 12, further comprising purging the halogen-containing precursor not adsorbed on the surface of the exposed region of the metal-containing material such that an atomic layer of the halogen-containing precursor is produced on the surface of the exposed region of the metal-containing material.
  • 14. The etching method of claim 12, wherein a temperature of the metal-containing material is maintained between about room temperature and about 300° C.
  • 15. The etching method of claim 12, wherein the metal-containing material comprises at least one of molybdenum, titanium, titanium nitride, tantalum, tantalum nitride, tungsten, or titanium tungsten.
  • 16. The etching method of claim 12, wherein the halogen-containing precursor comprises XeF2.
  • 17. The etching method of claim 12, further comprising: contacting an exposed region of a semiconductor material with the halogen-containing precursor such that the halogen-containing precursor is adsorbed on a surface of the exposed region of the semiconductor material;forming a film of the halogen-containing precursor on the surface of the exposed region of the semiconductor material;pausing the flow of the halogen-containing precursor into the processing region of the semiconductor processing chamber; andetching the exposed region of the semiconductor material with the adsorbed halogen-containing precursor on the surface of the exposed region of the semiconductor material, wherein the adsorbed halogen-containing precursor produces a fluoride of the semiconductor material.
  • 18. An etching method comprising: flowing a first halogen-containing precursor into a processing region of a semiconductor processing chamber, wherein the first halogen-containing precursor comprises a noble gas compound precursor;contacting an exposed region of a semiconductor material with the first halogen-containing precursor such that the first halogen-containing precursor is adsorbed on a surface of the exposed region of the semiconductor material;etching the exposed region of the semiconductor material with the adsorbed first halogen-containing precursor, wherein the adsorbed first halogen-containing precursor produces a gaseous byproduct; andforming a second halogen-containing precursor from the gaseous byproduct using plasma.
  • 19. The etching method of claim 18, further comprising: flowing the second halogen-containing precursor into the processing region of the semiconductor processing chamber;contacting the exposed region of the semiconductor material with the second halogen-containing precursor such that the second halogen-containing precursor is adsorbed on the surface of the exposed region of the semiconductor material; andetching the exposed region of the semiconductor material with the adsorbed second halogen-containing precursor, wherein the adsorbed second halogen-containing precursor produces a fluoride of the semiconductor material.
  • 20. The etching method of claim 18, wherein the gaseous byproduct comprises at least one of a noble gas or a halogen gas.
US Referenced Citations (2015)
Number Name Date Kind
2369620 Sullivan et al. Feb 1945 A
3401302 Thorpe Sep 1968 A
3451840 Hough Jun 1969 A
3537474 Rohrer Nov 1970 A
3756511 Shinroku Sep 1973 A
3937857 Brummett et al. Feb 1976 A
3969077 Hill Jul 1976 A
4006047 Brummett et al. Feb 1977 A
4190488 Winters Feb 1980 A
4209357 Gorin et al. Jun 1980 A
4214946 Forget et al. Jul 1980 A
4232060 Mallory, Jr. Nov 1980 A
4234628 DuRose Nov 1980 A
4265943 Goldstein et al. May 1981 A
4340462 Koch Jul 1982 A
4341592 Shortes et al. Jul 1982 A
4361418 Tscheppe Nov 1982 A
4361441 Tylko Nov 1982 A
4364803 Nidola et al. Dec 1982 A
4368223 Kobayashi et al. Jan 1983 A
4374698 Sanders et al. Feb 1983 A
4397812 Mallory, Jr. Aug 1983 A
4468413 Bachmann Aug 1984 A
4565601 Kakehi et al. Jan 1986 A
4579618 Celestino et al. Apr 1986 A
4585920 Hoog et al. Apr 1986 A
4600464 Desliets et al. Jul 1986 A
4610775 Phifer Sep 1986 A
4625678 Shloya et al. Dec 1986 A
4632857 Mallory, Jr. Dec 1986 A
4656052 Satou et al. Apr 1987 A
4656076 Vetanen et al. Apr 1987 A
4668335 Mockler May 1987 A
4690746 McInerney et al. Sep 1987 A
4715937 Moslehi et al. Dec 1987 A
4749440 Blackwood et al. Jun 1988 A
4753898 Parrillo et al. Jun 1988 A
4786360 Cote et al. Nov 1988 A
4792378 Rose et al. Dec 1988 A
4793897 Dunfield et al. Dec 1988 A
4807016 Douglas Feb 1989 A
4810520 Wu Mar 1989 A
4816638 Ukai et al. Mar 1989 A
4820377 Davis et al. Apr 1989 A
4828649 Davis May 1989 A
4857140 Loewenstein Aug 1989 A
4867841 Loewenstein et al. Sep 1989 A
4904621 Lowenstein et al. Feb 1990 A
4913929 Moslehi et al. Apr 1990 A
4919750 Bausmith et al. Apr 1990 A
4946903 Gardella et al. Aug 1990 A
4951601 Maydan et al. Aug 1990 A
4960488 Law et al. Oct 1990 A
4980018 Mu et al. Dec 1990 A
4981551 Palmour Jan 1991 A
4985372 Narita et al. Jan 1991 A
4991542 Kohmura et al. Feb 1991 A
4992136 Tachi et al. Feb 1991 A
4993358 Mahawili Feb 1991 A
4994404 Sheng et al. Feb 1991 A
5000113 Wang et al. Mar 1991 A
5006192 Deguchi Apr 1991 A
5010842 Oda et al. Apr 1991 A
5013691 Lory et al. May 1991 A
5028565 Chang Jul 1991 A
5030319 Nishino et al. Jul 1991 A
5038713 Kawakami et al. Aug 1991 A
5045244 Marlett Sep 1991 A
5061838 Lane et al. Oct 1991 A
5069938 Lorimer et al. Dec 1991 A
5074456 Degner et al. Dec 1991 A
5083030 Stavov Jan 1992 A
5089441 Moslehi Feb 1992 A
5089442 Olmer Feb 1992 A
5147692 Bengston Sep 1992 A
5156881 Okano et al. Oct 1992 A
5180435 Markunas et al. Jan 1993 A
5186718 Tepman et al. Feb 1993 A
5188706 Hori et al. Feb 1993 A
5198034 deBoer et al. Mar 1993 A
5200016 Namose Apr 1993 A
5203911 Sricharoenchalkit et al. Apr 1993 A
5215787 Homma Jun 1993 A
5221427 Koinuma et al. Jun 1993 A
5228501 Tepman et al. Jul 1993 A
5231690 Soma et al. Jul 1993 A
5235139 Bengston et al. Aug 1993 A
5238499 van de Ven et al. Aug 1993 A
5240497 Shacham et al. Aug 1993 A
5248371 Maher et al. Sep 1993 A
5248527 Uchida et al. Sep 1993 A
5252178 Moslehi Oct 1993 A
5266157 Kadomura Nov 1993 A
5269881 Sekiya Dec 1993 A
5270125 America et al. Dec 1993 A
5271972 Kwok et al. Dec 1993 A
5275977 Otsubo et al. Jan 1994 A
5277750 Wolgang Jan 1994 A
5279669 Lee Jan 1994 A
5279865 Chebi et al. Jan 1994 A
5288518 Homma Feb 1994 A
5290382 Zarowin et al. Mar 1994 A
5290383 Koshimizu Mar 1994 A
5292370 Tsai et al. Mar 1994 A
5292682 Stevens et al. Mar 1994 A
5300463 Cathey et al. Apr 1994 A
5302233 Kim et al. Apr 1994 A
5304250 Sameshima et al. Apr 1994 A
5306530 Strongin et al. Apr 1994 A
5314724 Tsukune et al. May 1994 A
5319247 Matsuura Jun 1994 A
5326427 Jerbic Jul 1994 A
5328558 Kawamura et al. Jul 1994 A
5328810 Lowrey et al. Jul 1994 A
5330578 Sakama Jul 1994 A
5334552 Homma Aug 1994 A
5345999 Hosokawa Sep 1994 A
5352636 Beinglass Oct 1994 A
5356478 Chen et al. Oct 1994 A
5362526 Wang et al. Nov 1994 A
5366585 Robertson et al. Nov 1994 A
5368897 Kurihara et al. Nov 1994 A
5378316 Franke et al. Jan 1995 A
5380560 Kaja et al. Jan 1995 A
5382311 Ishikawa et al. Jan 1995 A
5384284 Doan et al. Jan 1995 A
5385763 Okano et al. Jan 1995 A
5399237 Keswick et al. Mar 1995 A
5399529 Homma Mar 1995 A
5403434 Moslehi Apr 1995 A
5413670 Langan et al. May 1995 A
5413967 Matsuda et al. May 1995 A
5415890 Kloiber et al. May 1995 A
5416048 Blalock et al. May 1995 A
5420075 Homma et al. May 1995 A
5429995 Nishiyama et al. Jul 1995 A
5439553 Grant et al. Aug 1995 A
5451259 Krogh Sep 1995 A
5464499 Moslehi Nov 1995 A
5468342 Nulty et al. Nov 1995 A
5474589 Ohga et al. Dec 1995 A
5478403 Shinigawa et al. Dec 1995 A
5478462 Walsh Dec 1995 A
5483920 Pryor Jan 1996 A
5494494 Mizuno et al. Feb 1996 A
5500249 Telford et al. Mar 1996 A
5505816 Barnes et al. Apr 1996 A
5510216 Calabrese et al. Apr 1996 A
5516367 Lei et al. May 1996 A
5518962 Murao May 1996 A
5531835 Fodor et al. Jul 1996 A
5534070 Okamura et al. Jul 1996 A
5536360 Nguyen et al. Jul 1996 A
5549780 Koinuma et al. Aug 1996 A
5556521 Ghanbari Sep 1996 A
5558717 Zhao et al. Sep 1996 A
5560779 Knowles et al. Oct 1996 A
5563105 Dobuzinsky et al. Oct 1996 A
5567243 Foster et al. Oct 1996 A
5571576 Qian et al. Nov 1996 A
5575853 Arami et al. Nov 1996 A
5578130 Hayashi et al. Nov 1996 A
5578161 Auda Nov 1996 A
5580385 Paranjpe et al. Dec 1996 A
5580421 Hiatt et al. Dec 1996 A
5591269 Arami et al. Jan 1997 A
5592358 Shamouilian Jan 1997 A
5595606 Fujikawa et al. Jan 1997 A
5597439 Salzman Jan 1997 A
5599740 Jang et al. Feb 1997 A
5614055 Fairbairn et al. Mar 1997 A
5616518 Foo et al. Apr 1997 A
5624582 Cain Apr 1997 A
5626922 Miyanaga et al. May 1997 A
5628829 Foster et al. May 1997 A
5635086 Warren, Jr. Jun 1997 A
5645645 Zhang et al. Jul 1997 A
5648125 Cane Jul 1997 A
5648175 Russell et al. Jul 1997 A
5656093 Burkhart et al. Aug 1997 A
5660957 Chou et al. Aug 1997 A
5661093 Ravi et al. Aug 1997 A
5670066 Barnes et al. Sep 1997 A
5674787 Zhao et al. Oct 1997 A
5676758 Hasgawa et al. Oct 1997 A
5679606 Wang et al. Oct 1997 A
5685946 Fathauer et al. Nov 1997 A
5688331 Aruga et al. Nov 1997 A
5695810 Dubin et al. Dec 1997 A
5712185 Tsai et al. Jan 1998 A
5716500 Bardos et al. Feb 1998 A
5716506 Maclay et al. Feb 1998 A
5719085 Moon et al. Feb 1998 A
5733816 Iyer et al. Mar 1998 A
5747373 Yu May 1998 A
5753886 Iwamura et al. May 1998 A
5755859 Brusic et al. May 1998 A
5756400 Ye et al. May 1998 A
5756402 Jimbo et al. May 1998 A
5772770 Suda et al. Jun 1998 A
5781693 Ballance et al. Jul 1998 A
5786276 Brooks et al. Jul 1998 A
5788825 Park et al. Aug 1998 A
5789300 Fulford Aug 1998 A
5792376 Kanai et al. Aug 1998 A
5800686 Littau et al. Sep 1998 A
5804259 Robles Sep 1998 A
5812403 Fong et al. Sep 1998 A
5814238 Ashby et al. Sep 1998 A
5814365 Mahawill Sep 1998 A
5820723 Benjamin et al. Oct 1998 A
5824599 Schacham-Diamand et al. Oct 1998 A
5830805 Schacham-Diamand et al. Nov 1998 A
5835334 McMillin et al. Nov 1998 A
5843538 Ehrsam et al. Dec 1998 A
5843847 Pu et al. Dec 1998 A
5844195 Fairbairn et al. Dec 1998 A
5846332 Zhao et al. Dec 1998 A
5846373 Pirkle et al. Dec 1998 A
5846375 Gilchrist et al. Dec 1998 A
5846598 Semkow et al. Dec 1998 A
5849639 Molloy et al. Dec 1998 A
5850105 Dawson et al. Dec 1998 A
5855681 Maydan et al. Jan 1999 A
5855685 Tobe et al. Jan 1999 A
5856240 Sinha et al. Jan 1999 A
5858876 Chew Jan 1999 A
5863376 Wicker Jan 1999 A
5865896 Nowak Feb 1999 A
5866483 Shiau et al. Feb 1999 A
5868897 Ohkawa Feb 1999 A
5872052 Iyer Feb 1999 A
5872058 Van Cleemput et al. Feb 1999 A
5882424 Taylor et al. Mar 1999 A
5882786 Nassau et al. Mar 1999 A
5883012 Chiou Mar 1999 A
5885404 Kim et al. Mar 1999 A
5885749 Huggins et al. Mar 1999 A
5888906 Sandhu et al. Mar 1999 A
5891349 Tobe et al. Apr 1999 A
5891513 Dubin et al. Apr 1999 A
5897751 Makowiecki Apr 1999 A
5899752 Hey et al. May 1999 A
5900163 Yi et al. May 1999 A
5904827 Reynolds May 1999 A
5907790 Kellam May 1999 A
5910340 Uchida et al. Jun 1999 A
5913147 Dubin et al. Jun 1999 A
5913978 Kato et al. Jun 1999 A
5915190 Pirkle Jun 1999 A
5918116 Chittipeddi Jun 1999 A
5919332 Koshiishi et al. Jul 1999 A
5920792 Lin Jul 1999 A
5926737 Ameen et al. Jul 1999 A
5928528 Kubota et al. Jul 1999 A
5932077 Reynolds Aug 1999 A
5933757 Yoshikawa et al. Aug 1999 A
5935334 Fong et al. Aug 1999 A
5935340 Xia et al. Aug 1999 A
5937323 Orczyk et al. Aug 1999 A
5939831 Fong et al. Aug 1999 A
5942075 Nagahata et al. Aug 1999 A
5944049 Beyer et al. Aug 1999 A
5944902 Redeker et al. Aug 1999 A
5948702 Rotondaro Sep 1999 A
5951601 Lesinski et al. Sep 1999 A
5951776 Selyutin et al. Sep 1999 A
5951896 Mahawill Sep 1999 A
5953591 Ishihara et al. Sep 1999 A
5953635 Andideh Sep 1999 A
5963840 Xia et al. Oct 1999 A
5968379 Zhao et al. Oct 1999 A
5968587 Frankel et al. Oct 1999 A
5968610 Liu et al. Oct 1999 A
5969422 Ting et al. Oct 1999 A
5976327 Tanaka Nov 1999 A
5982100 Ghanbari Nov 1999 A
5990000 Hong et al. Nov 1999 A
5990013 Berenguer et al. Nov 1999 A
5993916 Zhao et al. Nov 1999 A
5994209 Yieh et al. Nov 1999 A
5997649 Hillman Dec 1999 A
5997962 Ogasawara et al. Dec 1999 A
6004884 Abraham Dec 1999 A
6007635 Mahawill Dec 1999 A
6007785 Liou Dec 1999 A
6010962 Liu et al. Jan 2000 A
6013191 Nasser-Faili et al. Jan 2000 A
6013584 M'Saad Jan 2000 A
6015724 Yamazaki et al. Jan 2000 A
6015747 Lopatin et al. Jan 2000 A
6017414 Koemtzopoulos et al. Jan 2000 A
6019848 Kiyama et al. Feb 2000 A
6020271 Yanagida Feb 2000 A
6030666 Lam et al. Feb 2000 A
6030881 Papasouliotis et al. Feb 2000 A
6035101 Sajoto et al. Mar 2000 A
6036878 Collins et al. Mar 2000 A
6037018 Jang et al. Mar 2000 A
6037266 Tao et al. Mar 2000 A
6039834 Tanaka et al. Mar 2000 A
6039851 Iyer Mar 2000 A
6053982 Halpin et al. Apr 2000 A
6059643 Hu et al. May 2000 A
6063683 Wu et al. May 2000 A
6063712 Gilton et al. May 2000 A
6065424 Shacham-Diamand et al. May 2000 A
6065425 Takaki et al. May 2000 A
6072147 Koshiishi Jun 2000 A
6072227 Yau et al. Jun 2000 A
6074512 Collins et al. Jun 2000 A
6074514 Bjorkman et al. Jun 2000 A
6077384 Collins et al. Jun 2000 A
6077386 Smith, Jr. et al. Jun 2000 A
6077780 Dubin Jun 2000 A
6079356 Umotoy et al. Jun 2000 A
6080529 Ye et al. Jun 2000 A
6081414 Flanigan et al. Jun 2000 A
6083344 Hanawa et al. Jul 2000 A
6083844 Bui-Le et al. Jul 2000 A
6086677 Umotoy et al. Jul 2000 A
6087278 Kim et al. Jul 2000 A
6090212 Mahawill Jul 2000 A
6093457 Okumura Jul 2000 A
6093594 Yeap et al. Jul 2000 A
6099697 Hausmann Aug 2000 A
6107199 Allen et al. Aug 2000 A
6110530 Chen et al. Aug 2000 A
6110832 Morgan et al. Aug 2000 A
6110836 Cohen et al. Aug 2000 A
6110838 Loewenstein Aug 2000 A
6113771 Landau et al. Sep 2000 A
6114216 Yieh et al. Sep 2000 A
6117245 Mandrekar et al. Sep 2000 A
6120640 Shih et al. Sep 2000 A
6124003 Mikami et al. Sep 2000 A
6126753 Shinriki et al. Oct 2000 A
6132512 Horie et al. Oct 2000 A
6136163 Cheung et al. Oct 2000 A
6136165 Moslehi et al. Oct 2000 A
6136685 Narwankar et al. Oct 2000 A
6136693 Chan et al. Oct 2000 A
6140234 Uzoh et al. Oct 2000 A
6144099 Lopatin et al. Nov 2000 A
6147009 Grill et al. Nov 2000 A
6148761 Majewski et al. Nov 2000 A
6149828 Vaartstra Nov 2000 A
6150628 Smith et al. Nov 2000 A
6153935 Edelstein et al. Nov 2000 A
6161500 Kopacz et al. Dec 2000 A
6161576 Maher et al. Dec 2000 A
6162302 Raghavan et al. Dec 2000 A
6162370 Hackett et al. Dec 2000 A
6165912 McConnell et al. Dec 2000 A
6167834 Wang et al. Jan 2001 B1
6169021 Akram et al. Jan 2001 B1
6170428 Redeker et al. Jan 2001 B1
6171661 Zheng et al. Jan 2001 B1
6174450 Patrick et al. Jan 2001 B1
6174810 Patrick et al. Jan 2001 B1
6174812 Hsuing et al. Jan 2001 B1
6176198 Kao et al. Jan 2001 B1
6176667 Fairbairn Jan 2001 B1
6177245 Ward et al. Jan 2001 B1
6179924 Zhao et al. Jan 2001 B1
6180523 Lee et al. Jan 2001 B1
6182602 Redeker et al. Feb 2001 B1
6182603 Shang et al. Feb 2001 B1
6184121 Buchwalter et al. Feb 2001 B1
6184489 Ito et al. Feb 2001 B1
6186091 Chu et al. Feb 2001 B1
6189483 Ishikawa et al. Feb 2001 B1
6190233 Hong et al. Feb 2001 B1
6194038 Rossman Feb 2001 B1
6197181 Chen Mar 2001 B1
6197364 Paunovic et al. Mar 2001 B1
6197680 Lin et al. Mar 2001 B1
6197688 Simpson Mar 2001 B1
6197705 Vassiliev Mar 2001 B1
6198616 Dahimene et al. Mar 2001 B1
6200412 Kilgore et al. Mar 2001 B1
6203863 Liu et al. Mar 2001 B1
6204200 Shieh et al. Mar 2001 B1
6210486 Mizukami et al. Apr 2001 B1
6217658 Orczyk et al. Apr 2001 B1
6220201 Nowak Apr 2001 B1
6225745 Srivastava May 2001 B1
6228233 Lakshmikanthan et al. May 2001 B1
6228751 Yamazaki et al. May 2001 B1
6228758 Pellerin et al. May 2001 B1
6235643 Mui et al. May 2001 B1
6237527 Kellerman et al. May 2001 B1
6238513 Arnold et al. May 2001 B1
6238582 Williams et al. May 2001 B1
6197151 Kaji et al. Jun 2001 B1
6241845 Gadgil et al. Jun 2001 B1
6242349 Nogami et al. Jun 2001 B1
6242360 Fischer et al. Jun 2001 B1
6244211 Nishikawa et al. Jun 2001 B1
6245396 Nogami Jun 2001 B1
6245670 Cheung et al. Jun 2001 B1
6251236 Stevens Jun 2001 B1
6251802 Moore et al. Jun 2001 B1
6258170 Somekh et al. Jul 2001 B1
6258220 Dordi et al. Jul 2001 B1
6258223 Cheung et al. Jul 2001 B1
6258270 Hilgendorff et al. Jul 2001 B1
6261637 Oberle Jul 2001 B1
6267074 Okumura Jul 2001 B1
6277733 Smith Aug 2001 B1
6277752 Chen Aug 2001 B1
6277763 Kugimiya et al. Aug 2001 B1
6281072 Li et al. Aug 2001 B1
6281135 Han et al. Aug 2001 B1
6284146 Kim et al. Sep 2001 B1
6291282 Wilk et al. Sep 2001 B1
6291348 Lopatin et al. Sep 2001 B1
6302964 Umotoy et al. Oct 2001 B1
6303044 Koemtzopoulos Oct 2001 B1
6303418 Cha et al. Oct 2001 B1
6306246 Melvin et al. Oct 2001 B1
6306772 Lin Oct 2001 B1
6308654 Schneider et al. Oct 2001 B1
6308776 Sloan Oct 2001 B1
6310755 Busato et al. Oct 2001 B1
6312554 Ye Nov 2001 B1
6312995 Yu Nov 2001 B1
6319387 Krishnamoorthy et al. Nov 2001 B1
6321587 Laush Nov 2001 B1
6322716 Qiao et al. Nov 2001 B1
6323128 Sambucetti et al. Nov 2001 B1
6335288 Kwan et al. Jan 2002 B1
6340435 Bjorkman et al. Jan 2002 B1
6342733 Hu et al. Jan 2002 B1
RE37546 Mahawili Feb 2002 E
6344410 Lopatin et al. Feb 2002 B1
6348407 Gupta et al. Feb 2002 B1
6350320 Sherstinsky et al. Feb 2002 B1
6350697 Richardson Feb 2002 B1
6351013 Luning et al. Feb 2002 B1
6352081 Lu et al. Mar 2002 B1
6355573 Okumura Mar 2002 B1
6358827 Chen et al. Mar 2002 B1
6364949 Or et al. Apr 2002 B1
6364954 Umotoy et al. Apr 2002 B2
6364957 Schneider et al. Apr 2002 B1
6375748 Yudovsky et al. Apr 2002 B1
6376386 Oshima Apr 2002 B1
6379575 Yin et al. Apr 2002 B1
6383896 Kirimura et al. May 2002 B1
6383951 Li May 2002 B1
6387207 Janakiraman et al. May 2002 B1
6391753 Yu May 2002 B1
6395150 Van Cleemput et al. May 2002 B1
6403491 Liu et al. Jun 2002 B1
6415736 Hao et al. Jul 2002 B1
6416647 Dordi et al. Jul 2002 B1
6418874 Cox et al. Jul 2002 B1
6423284 Arno Jul 2002 B1
6427623 Ko Aug 2002 B2
6429465 Yagi et al. Aug 2002 B1
6432819 Pavate et al. Aug 2002 B1
6432831 Dhindsa et al. Aug 2002 B2
6436193 Kasai et al. Aug 2002 B1
6436816 Lee et al. Aug 2002 B1
6440863 Tsai et al. Aug 2002 B1
6441492 Cunningham Aug 2002 B1
6446572 Brcka Sep 2002 B1
6447636 Qian et al. Sep 2002 B1
6448537 Nering Sep 2002 B1
6458718 Todd Oct 2002 B1
6461974 Ni et al. Oct 2002 B1
6462371 Weimer et al. Oct 2002 B1
6462372 Xia et al. Oct 2002 B1
6465051 Sahin et al. Oct 2002 B1
6465350 Taylor et al. Oct 2002 B1
6465366 Nemani et al. Oct 2002 B1
6477980 White et al. Nov 2002 B1
6479373 Dreybrodt et al. Nov 2002 B2
6488984 Wada et al. Dec 2002 B1
6494959 Samoilov et al. Dec 2002 B1
6499425 Sandhu et al. Dec 2002 B1
6500728 Wang Dec 2002 B1
6503843 Xia et al. Jan 2003 B1
6506291 Tsai et al. Jan 2003 B2
6509283 Thomas Jan 2003 B1
6509623 Zhao Jan 2003 B2
6516815 Stevens et al. Feb 2003 B1
6518548 Sugaya et al. Feb 2003 B2
6527968 Wang et al. Mar 2003 B1
6528409 Lopatin et al. Mar 2003 B1
6528751 Hoffman et al. Mar 2003 B1
6531069 Srivastava et al. Mar 2003 B1
6537707 Lee Mar 2003 B1
6537733 Campana et al. Mar 2003 B2
6541397 Bencher Apr 2003 B1
6541671 Martinez et al. Apr 2003 B1
6544340 Yudovsky Apr 2003 B2
6547977 Yan et al. Apr 2003 B1
6551924 Dalton et al. Apr 2003 B1
6558564 Loewenhardt May 2003 B1
6565661 Nguyen May 2003 B1
6565729 Chen et al. May 2003 B2
6569773 Gellrich et al. May 2003 B1
6572937 Hakovirta et al. Jun 2003 B2
6573030 Fairbairn et al. Jun 2003 B1
6573606 Sambucetti et al. Jun 2003 B2
6585851 Ohmi et al. Jul 2003 B1
6586163 Okabe et al. Jul 2003 B1
6596599 Guo Jul 2003 B1
6596654 Bayman et al. Jul 2003 B1
6602434 Hung et al. Aug 2003 B1
6602806 Xia et al. Aug 2003 B1
6603269 Vo et al. Aug 2003 B1
6605874 Leu et al. Aug 2003 B2
6616967 Test Sep 2003 B1
6627532 Gaillard et al. Sep 2003 B1
6635575 Xia et al. Oct 2003 B1
6635578 Xu et al. Oct 2003 B1
6638810 Bakli et al. Oct 2003 B2
6645301 Sainty et al. Nov 2003 B2
6645550 Cheung et al. Nov 2003 B1
6656831 Lee et al. Dec 2003 B1
6656837 Xu et al. Dec 2003 B2
6656848 Scanlan et al. Dec 2003 B1
6663715 Yuda et al. Dec 2003 B1
6673200 Gu et al. Jan 2004 B1
6677242 Liu et al. Jan 2004 B1
6679981 Pan et al. Jan 2004 B1
6688375 Turner Feb 2004 B1
6713356 Skotnicki et al. Mar 2004 B1
6713835 Horak et al. Mar 2004 B1
6717189 Inoue et al. Apr 2004 B2
6720213 Gambino et al. Apr 2004 B1
6736147 Satoh et al. May 2004 B2
6736987 Cho May 2004 B1
6740247 Han et al. May 2004 B1
6740585 Yoon et al. May 2004 B2
6740977 Ahn et al. May 2004 B2
6743473 Parkhe et al. Jun 2004 B1
6743732 Lin et al. Jun 2004 B1
6756235 Liu et al. Jun 2004 B1
6759261 Shimokohbe et al. Jul 2004 B2
6762127 Boiteux et al. Jul 2004 B2
6762435 Towle Jul 2004 B2
6764958 Nemani et al. Jul 2004 B1
6765273 Chau et al. Jul 2004 B1
6767834 Chung et al. Jul 2004 B2
6768079 Kosakai Jul 2004 B2
6770166 Fisher Aug 2004 B1
6772827 Keller et al. Aug 2004 B2
6792889 Nakano et al. Sep 2004 B2
6794290 Papasouliotis et al. Sep 2004 B1
6794311 Huang et al. Sep 2004 B2
6796314 Graff et al. Sep 2004 B1
6797189 Hung et al. Sep 2004 B2
6800336 Fornsel et al. Oct 2004 B1
6800830 Mahawili Oct 2004 B2
6802944 Ahmad et al. Oct 2004 B2
6808564 Dietze Oct 2004 B2
6808747 Shih et al. Oct 2004 B1
6808748 Kapoor et al. Oct 2004 B2
6815633 Chen et al. Nov 2004 B1
6821571 Huang Nov 2004 B2
6823589 White et al. Nov 2004 B2
6828241 Kholodenko et al. Dec 2004 B2
6830624 Janakiraman et al. Dec 2004 B2
6835995 Li Dec 2004 B2
6846745 Papasouliotis et al. Jan 2005 B1
6849854 Sainty Feb 2005 B2
6852550 Tuttle et al. Feb 2005 B2
6852584 Chen et al. Feb 2005 B1
6853533 Parkhe et al. Feb 2005 B2
6858153 Bjorkman et al. Feb 2005 B2
6861097 Goosey et al. Mar 2005 B1
6861332 Park et al. Mar 2005 B2
6869880 Krishnaraj et al. Mar 2005 B2
6875280 Ikeda et al. Apr 2005 B2
6878206 Tzu et al. Apr 2005 B2
6879981 Rothschild et al. Apr 2005 B2
6886491 Kim et al. May 2005 B2
6892669 Xu et al. May 2005 B2
6893967 Wright et al. May 2005 B1
6897532 Schwarz et al. May 2005 B1
6900596 Yang et al. May 2005 B2
6903511 Chistyakov Jun 2005 B2
6908862 Li et al. Jun 2005 B2
6911112 An Jun 2005 B2
6911401 Khandan et al. Jun 2005 B2
6916399 Rozenzon et al. Jul 2005 B1
6921556 Shimizu et al. Jul 2005 B2
6924191 Liu et al. Aug 2005 B2
6930047 Yamazaki Aug 2005 B2
6935269 Lee et al. Aug 2005 B2
6942753 Choi et al. Sep 2005 B2
6946033 Tsuel et al. Sep 2005 B2
6951821 Hamelin et al. Oct 2005 B2
6958175 Sakamoto et al. Oct 2005 B2
6958286 Chen et al. Oct 2005 B2
6969619 Winniczek Nov 2005 B1
6972840 Gu et al. Dec 2005 B1
6995073 Liou Feb 2006 B2
7017269 White et al. Mar 2006 B2
7018941 Cui et al. Mar 2006 B2
7030034 Fucsko et al. Apr 2006 B2
7049200 Arghavani et al. May 2006 B2
7052553 Shih et al. May 2006 B1
7071532 Geffken et al. Jul 2006 B2
7084070 Lee et al. Aug 2006 B1
7115525 Abatchev et al. Oct 2006 B2
7122949 Strikovski Oct 2006 B2
7138767 Chen et al. Nov 2006 B2
7145725 Hasel et al. Dec 2006 B2
7148155 Tarafdar et al. Dec 2006 B1
7166233 Johnson et al. Jan 2007 B2
7183214 Nam et al. Feb 2007 B2
7196342 Ershov et al. Mar 2007 B2
7226805 Hallin et al. Jun 2007 B2
7235137 Kitayama et al. Jun 2007 B2
7244474 Hanawa et al. Jul 2007 B2
7252011 Traverso Aug 2007 B2
7252716 Kim et al. Aug 2007 B2
7253123 Arghavani et al. Aug 2007 B2
7256370 Guiver Aug 2007 B2
7274004 Benjamin et al. Sep 2007 B2
7288482 Panda et al. Oct 2007 B2
7291360 Hanawa et al. Nov 2007 B2
7297894 Tsukamoto Nov 2007 B1
7316761 Doan et al. Jan 2008 B2
7329608 Babayan et al. Feb 2008 B2
7341633 Lubomirsky et al. Mar 2008 B2
7344912 Okoroanyanwu Mar 2008 B1
7358192 Merry et al. Apr 2008 B2
7361865 Maki et al. Apr 2008 B2
7364956 Saito Apr 2008 B2
7365016 Ouellet et al. Apr 2008 B2
7396480 Kao et al. Jul 2008 B2
7396773 Blosse et al. Jul 2008 B1
7416989 Liu et al. Aug 2008 B1
7465358 Weidman et al. Dec 2008 B2
7465953 Koh et al. Dec 2008 B1
7468319 Lee Dec 2008 B2
7479303 Byun et al. Jan 2009 B2
7484473 Keller et al. Feb 2009 B2
7488688 Chung et al. Feb 2009 B2
7494545 Lam et al. Feb 2009 B2
7500445 Zhao et al. Mar 2009 B2
7504040 Lijima et al. Mar 2009 B2
7513214 Okumura et al. Apr 2009 B2
7520957 Kao et al. Apr 2009 B2
7553756 Hayashi et al. Jun 2009 B2
7575007 Tang et al. Aug 2009 B2
7581511 Mardian et al. Sep 2009 B2
7604708 Wood et al. Oct 2009 B2
7611980 Wells Nov 2009 B2
7628897 Mungekar et al. Dec 2009 B2
7658799 Ishikawa et al. Feb 2010 B2
7682518 Chandrachood et al. Mar 2010 B2
7695590 Hanawa et al. Apr 2010 B2
7708859 Huang et al. May 2010 B2
7722925 White et al. May 2010 B2
7723221 Hayashi May 2010 B2
7749326 Kim et al. Jul 2010 B2
7780790 Nogami Aug 2010 B2
7785672 Choi et al. Aug 2010 B2
7790634 Munro et al. Sep 2010 B2
7806077 Lee et al. Oct 2010 B2
7806078 Yoshida Oct 2010 B2
7807578 Bencher et al. Oct 2010 B2
7825038 Ingle et al. Nov 2010 B2
7837828 Ikeda et al. Nov 2010 B2
7845309 Condrashoff et al. Dec 2010 B2
7867926 Satoh et al. Jan 2011 B2
7906818 Pekny Mar 2011 B2
7915139 Lang et al. Mar 2011 B1
7922863 Ripley Apr 2011 B2
7932181 Singh et al. Apr 2011 B2
7939422 Ingle et al. May 2011 B2
7968441 Xu Jun 2011 B2
7976631 Burrows Jul 2011 B2
7977249 Liu Jul 2011 B1
7981806 Jung Jul 2011 B2
7989365 Park et al. Aug 2011 B2
8008166 Sanchez et al. Aug 2011 B2
8048811 Feustel et al. Nov 2011 B2
8058179 Draeger et al. Nov 2011 B1
8071482 Kawada Dec 2011 B2
8074599 Choi et al. Dec 2011 B2
8076198 Lee et al. Dec 2011 B2
8083853 Choi et al. Dec 2011 B2
8114245 Ohmi et al. Feb 2012 B2
8119530 Hori et al. Feb 2012 B2
8133349 Panagopoulos Mar 2012 B1
8173228 Choi et al. May 2012 B2
8183134 Wu May 2012 B2
8187486 Liu et al. May 2012 B1
8199454 Koyama et al. Jun 2012 B2
8211808 Sapre et al. Jul 2012 B2
8216486 Dhindsa Jul 2012 B2
8222128 Sasaki et al. Jul 2012 B2
8252194 Kiehlbauch et al. Aug 2012 B2
8272346 Bettencourt et al. Sep 2012 B2
8295089 Jeong et al. Oct 2012 B2
8298627 Minami et al. Oct 2012 B2
8298959 Cheshire Oct 2012 B2
8309440 Sanchez et al. Nov 2012 B2
8312839 Baek Nov 2012 B2
8313610 Dhindsa Nov 2012 B2
8328939 Choi et al. Dec 2012 B2
8329262 Miller et al. Dec 2012 B2
8336188 Monteen Dec 2012 B2
8343306 Tanaka et al. Jan 2013 B2
8357435 Lubomirsky Jan 2013 B2
8361892 Tam et al. Jan 2013 B2
8368308 Banna et al. Feb 2013 B2
8390980 Sansoni et al. Mar 2013 B2
8427067 Espiau et al. Apr 2013 B2
8435902 Tang et al. May 2013 B2
8440523 Guillorn et al. May 2013 B1
8466073 Wang et al. Jun 2013 B2
8475674 Thadani et al. Jul 2013 B2
8480850 Tyler et al. Jul 2013 B2
8491805 Kushibiki et al. Jul 2013 B2
8501629 Tang et al. Aug 2013 B2
8506713 Takagi Aug 2013 B2
8512509 Bera et al. Aug 2013 B2
8528889 Sansoni et al. Sep 2013 B2
8540844 Hudson et al. Sep 2013 B2
8551891 Liang Oct 2013 B2
8573152 De La Llera Nov 2013 B2
8622021 Taylor et al. Jan 2014 B2
8623471 Tyler et al. Jan 2014 B2
8633423 Lin et al. Jan 2014 B2
8642481 Wang et al. Feb 2014 B2
8652298 Dhindsa et al. Feb 2014 B2
8668836 Mizukami et al. Mar 2014 B2
8679982 Wang et al. Mar 2014 B2
8679983 Wang et al. Mar 2014 B2
8691023 Bao et al. Apr 2014 B2
8702902 Blom et al. Apr 2014 B2
8741778 Yang et al. Jun 2014 B2
8747610 Chen et al. Jun 2014 B2
8747680 Deshpande Jun 2014 B1
8748322 Fung et al. Jun 2014 B1
8765574 Zhang et al. Jul 2014 B2
8771536 Zhang et al. Jul 2014 B2
8771539 Zhang et al. Jul 2014 B2
8772888 Jung et al. Jul 2014 B2
8778079 Begarney et al. Jul 2014 B2
8801952 Wang et al. Aug 2014 B1
8802572 Nemani et al. Aug 2014 B2
8808563 Wang et al. Aug 2014 B2
8815720 Godet et al. Aug 2014 B2
8835316 Yin et al. Sep 2014 B2
8846163 Kao et al. Sep 2014 B2
8869742 Dhindsa Oct 2014 B2
8871651 Choi et al. Oct 2014 B1
8888087 Okabe et al. Nov 2014 B2
8894767 Goradia et al. Nov 2014 B2
8895449 Zhu et al. Nov 2014 B1
8900364 Wright Dec 2014 B2
8921234 Liu et al. Dec 2014 B2
8927390 Sapre et al. Jan 2015 B2
8932947 Han et al. Jan 2015 B1
8937017 Cheshire et al. Jan 2015 B2
8945414 Su et al. Feb 2015 B1
8946665 Shim et al. Feb 2015 B2
8946828 Sun et al. Feb 2015 B2
8951429 Liu et al. Feb 2015 B1
8956980 Chen et al. Feb 2015 B1
8969212 Ren et al. Mar 2015 B2
8970114 Busche et al. Mar 2015 B2
8980005 Carlson et al. Mar 2015 B2
8980758 Ling et al. Mar 2015 B1
8980763 Wang et al. Mar 2015 B2
8992723 Sorensen et al. Mar 2015 B2
8999656 Jirstrom et al. Apr 2015 B2
8999839 Su et al. Apr 2015 B2
8999856 Zhang et al. Apr 2015 B2
9012302 Sapre et al. Apr 2015 B2
9017481 Pettinger et al. Apr 2015 B1
9023732 Wang et al. May 2015 B2
9023734 Chen et al. May 2015 B2
9034770 Park et al. May 2015 B2
9040422 Wang et al. May 2015 B2
9064815 Zhang et al. Jun 2015 B2
9064816 Kim et al. Jun 2015 B2
9068265 Lubomirsky et al. Jun 2015 B2
9072158 Ikeda et al. Jun 2015 B2
9093371 Wang et al. Jul 2015 B2
9093389 Nemani Jul 2015 B2
9093390 Wang et al. Jul 2015 B2
9111877 Chen et al. Aug 2015 B2
9111907 Kamineni Aug 2015 B2
9114438 Hoinkis et al. Aug 2015 B2
9117855 Cho et al. Aug 2015 B2
9132436 Liang et al. Sep 2015 B2
9136273 Purayath et al. Sep 2015 B1
9144147 Yang et al. Sep 2015 B2
9153442 Wang et al. Oct 2015 B2
9159606 Purayath et al. Oct 2015 B1
9165783 Nemani et al. Oct 2015 B2
9165786 Purayath et al. Oct 2015 B1
9184055 Wang et al. Nov 2015 B2
9190290 Xue et al. Nov 2015 B2
9190293 Wang et al. Nov 2015 B2
9190302 Ni Nov 2015 B2
9202708 Chen et al. Dec 2015 B1
9209012 Chen et al. Dec 2015 B2
9236265 Korolik et al. Jan 2016 B2
9236266 Zhang et al. Jan 2016 B2
9240315 Hsieh et al. Jan 2016 B1
9245762 Zhang et al. Jan 2016 B2
9263278 Purayath et al. Feb 2016 B2
9269590 Luere et al. Feb 2016 B2
9275834 Park et al. Mar 2016 B1
9281384 Takeguchi Mar 2016 B2
9287095 Nguyen et al. Mar 2016 B2
9287134 Wang et al. Mar 2016 B2
9293568 Ko Mar 2016 B2
9299537 Kobayashi et al. Mar 2016 B2
9299538 Kobayashi et al. Mar 2016 B2
9299575 Park et al. Mar 2016 B2
9299582 Ingle et al. Mar 2016 B2
9299583 Wang et al. Mar 2016 B1
9309598 Wang et al. Apr 2016 B2
9324576 Zhang et al. Apr 2016 B2
9343272 Pandit et al. May 2016 B1
9343327 Zhang et al. May 2016 B2
9349605 Xu et al. May 2016 B1
9355856 Wang et al. May 2016 B2
9355862 Pandit et al. May 2016 B2
9355863 Chen et al. May 2016 B2
9355922 Park et al. May 2016 B2
9362130 Ingle et al. Jun 2016 B2
9362163 Danek et al. Jun 2016 B2
9368364 Park et al. Jun 2016 B2
9373517 Yang et al. Jun 2016 B2
9373522 Wang et al. Jun 2016 B1
9378969 Hsu et al. Jun 2016 B2
9378978 Purayath et al. Jun 2016 B2
9384997 Ren et al. Jul 2016 B2
9385028 Nemani et al. Jul 2016 B2
9390937 Chen et al. Jul 2016 B2
9396961 Arghavani et al. Jul 2016 B2
9396989 Purayath et al. Jul 2016 B2
9406523 Chen et al. Aug 2016 B2
9412608 Wang et al. Aug 2016 B2
9412752 Yeh et al. Aug 2016 B1
9418858 Wang et al. Aug 2016 B2
9425041 Berry et al. Aug 2016 B2
9425058 Kim et al. Aug 2016 B2
9431268 Lill et al. Aug 2016 B2
9431414 Jang et al. Aug 2016 B2
9343358 Montgomery Sep 2016 B1
9437451 Chen et al. Sep 2016 B2
9443749 Smith Sep 2016 B2
9449845 Liu et al. Sep 2016 B2
9449846 Liu et al. Sep 2016 B2
9449850 Wang et al. Sep 2016 B2
9460959 Xie et al. Oct 2016 B1
9466469 Khaja Oct 2016 B2
9472412 Zhang et al. Oct 2016 B2
9472417 Ingle et al. Oct 2016 B2
9478432 Chen et al. Oct 2016 B2
9478433 Zhou et al. Oct 2016 B1
9478434 Wang et al. Oct 2016 B2
9493879 Hoinkis et al. Nov 2016 B2
9496167 Purayath et al. Nov 2016 B2
9499898 Nguyen et al. Nov 2016 B2
9502258 Xue et al. Nov 2016 B2
9508529 Valcore et al. Nov 2016 B2
9520303 Wang et al. Dec 2016 B2
9543163 Ling et al. Jan 2017 B2
9564296 Kobayashi et al. Feb 2017 B2
9564338 Zhang et al. Feb 2017 B1
9576788 Liu et al. Feb 2017 B2
9576809 Korolik et al. Feb 2017 B2
9607856 Wang et al. Mar 2017 B2
9613822 Chen et al. Apr 2017 B2
9659753 Cho et al. May 2017 B2
9659791 Wang et al. May 2017 B2
9659792 Wang et al. May 2017 B2
9666449 Koval et al. May 2017 B2
9691645 Benjaminson et al. Jun 2017 B2
9704723 Wang et al. Jul 2017 B2
9711366 Ingle et al. Jul 2017 B2
9721789 Yang et al. Aug 2017 B1
9728437 Tran et al. Aug 2017 B2
9741593 Benjaminson et al. Aug 2017 B2
9754800 Zhang et al. Sep 2017 B2
9768034 Xu et al. Sep 2017 B1
9773648 Cho et al. Sep 2017 B2
9773695 Purayath et al. Sep 2017 B2
9779956 Zhang et al. Oct 2017 B1
9812462 Pang et al. Nov 2017 B1
9822009 Kagaya et al. Nov 2017 B2
9831097 Ingle et al. Nov 2017 B2
9837249 Kobayashi et al. Dec 2017 B2
9837284 Chen et al. Dec 2017 B2
9837286 Yang et al. Dec 2017 B2
9842744 Zhang et al. Dec 2017 B2
9865484 Citla et al. Jan 2018 B1
9881805 Li et al. Jan 2018 B2
9885117 Lubomirsky et al. Feb 2018 B2
9887096 Park et al. Feb 2018 B2
9903020 Kim et al. Feb 2018 B2
9934942 Lubomirsky Apr 2018 B1
9941097 Yamazawa Apr 2018 B2
9947549 Park et al. Apr 2018 B1
9960045 Purayath et al. May 2018 B1
9966240 Park et al. May 2018 B2
9978564 Liang et al. May 2018 B2
9991134 Wang et al. Jun 2018 B2
10032606 Yang et al. Jul 2018 B2
10043674 Korolik et al. Aug 2018 B1
10043684 Arnepalli Aug 2018 B1
10049891 Wang et al. Aug 2018 B1
10062578 Zhang et al. Aug 2018 B2
10062579 Chen et al. Aug 2018 B2
10062585 Lubomirsky Aug 2018 B2
10062587 Chen et al. Aug 2018 B2
10083830 Seino et al. Sep 2018 B2
10147620 Benjaminson et al. Dec 2018 B2
10147736 Linuma Dec 2018 B2
10269541 Stowell et al. Apr 2019 B2
20010003014 Yuda Jun 2001 A1
20010006093 Tabuchi Jul 2001 A1
20010008803 Takamatsu et al. Jul 2001 A1
20010015175 Masuda et al. Aug 2001 A1
20010015261 Kobayashi et al. Aug 2001 A1
20010023741 Collison et al. Sep 2001 A1
20010028093 Yamazaki et al. Oct 2001 A1
20010028922 Sandhu Oct 2001 A1
20010029891 Oh et al. Oct 2001 A1
20010030366 Nakano et al. Oct 2001 A1
20010034106 Moise et al. Oct 2001 A1
20010034121 Fu et al. Oct 2001 A1
20010035124 Okayama et al. Nov 2001 A1
20010036706 Kitamura Nov 2001 A1
20010037856 Park Nov 2001 A1
20010037941 Thompson Nov 2001 A1
20010039921 Rolfson et al. Nov 2001 A1
20010042512 Xu et al. Nov 2001 A1
20010042799 Kim et al. Nov 2001 A1
20010047760 Moslehi Dec 2001 A1
20010053585 Kikuchi et al. Dec 2001 A1
20010053610 Athavale Dec 2001 A1
20010054381 Umotoy et al. Dec 2001 A1
20010054387 Frankel et al. Dec 2001 A1
20020000202 Yuda et al. Jan 2002 A1
20020001778 Latchford et al. Jan 2002 A1
20020009560 Ozono Jan 2002 A1
20020009885 Brankner et al. Jan 2002 A1
20020011210 Satoh et al. Jan 2002 A1
20020011214 Kamarehi et al. Jan 2002 A1
20020016080 Khan et al. Feb 2002 A1
20020016085 Huang et al. Feb 2002 A1
20020023899 Khater et al. Feb 2002 A1
20020028582 Nallan et al. Mar 2002 A1
20020028585 Chung et al. Mar 2002 A1
20020029747 Powell et al. Mar 2002 A1
20020033233 Savas Mar 2002 A1
20020036143 Segawa et al. Mar 2002 A1
20020040764 Kwan et al. Apr 2002 A1
20020040766 Takahashi Apr 2002 A1
20020043690 Doyle et al. Apr 2002 A1
20020045966 Lee et al. Apr 2002 A1
20020046991 Smith et al. Apr 2002 A1
20020054962 Huang May 2002 A1
20020062954 Getchel et al. May 2002 A1
20020069820 Yudovsky Jun 2002 A1
20020070414 Drescher et al. Jun 2002 A1
20020073925 Noble et al. Jun 2002 A1
20020074573 Takeuchi et al. Jun 2002 A1
20020075624 Wang et al. Jun 2002 A1
20020086501 O'Donnell et al. Jul 2002 A1
20020090781 Skotnicki et al. Jul 2002 A1
20020090835 Chakravarti et al. Jul 2002 A1
20020094378 O'Donnell Jul 2002 A1
20020094591 Sill et al. Jul 2002 A1
20020096493 Hattori Jul 2002 A1
20020098681 Hu et al. Jul 2002 A1
20020106845 Chao et al. Aug 2002 A1
20020112819 Kamarehi et al. Aug 2002 A1
20020124867 Kim et al. Sep 2002 A1
20020129769 Kim et al. Sep 2002 A1
20020129902 Babayan et al. Sep 2002 A1
20020144657 Chiang et al. Oct 2002 A1
20020153808 Skotnicki et al. Oct 2002 A1
20020164885 Lill et al. Nov 2002 A1
20020170678 Hayashi et al. Nov 2002 A1
20020177322 Li et al. Nov 2002 A1
20020179248 Kabansky et al. Dec 2002 A1
20020182878 Hirose et al. Dec 2002 A1
20020187280 Johnson et al. Dec 2002 A1
20020187655 Tan et al. Dec 2002 A1
20020197823 Yoo et al. Dec 2002 A1
20030000647 Yudovsky et al. Jan 2003 A1
20030003757 Naltan et al. Jan 2003 A1
20030007910 Lazarovich et al. Jan 2003 A1
20030010645 Ting et al. Jan 2003 A1
20030015515 Ito et al. Jan 2003 A1
20030019428 Ku et al. Jan 2003 A1
20030019580 Strang Jan 2003 A1
20030026060 Hiramatsu et al. Feb 2003 A1
20030029566 Roth Feb 2003 A1
20030029567 Dhindsa et al. Feb 2003 A1
20030029715 Yu et al. Feb 2003 A1
20030031905 Saito et al. Feb 2003 A1
20030032284 Enomoto et al. Feb 2003 A1
20030038127 Liu et al. Feb 2003 A1
20030038305 Wasshuber Feb 2003 A1
20030054608 Tseng et al. Mar 2003 A1
20030066482 Pokharna et al. Apr 2003 A1
20030071035 Brailove Apr 2003 A1
20030072639 White et al. Apr 2003 A1
20030075808 Inoue et al. Apr 2003 A1
20030077857 Xia et al. Apr 2003 A1
20030077909 Jiwari Apr 2003 A1
20030079686 Chen et al. May 2003 A1
20030087488 Fink May 2003 A1
20030087531 Kang et al. May 2003 A1
20030091938 Fairbairn et al. May 2003 A1
20030094134 Minami et al. May 2003 A1
20030098125 An May 2003 A1
20030109143 Hsieh et al. Jun 2003 A1
20030116087 Nguyen et al. Jun 2003 A1
20030116439 Seo et al. Jun 2003 A1
20030121608 Chen et al. Jul 2003 A1
20030121609 Ohmi et al. Jul 2003 A1
20030124465 Lee et al. Jul 2003 A1
20030124842 Hytros et al. Jul 2003 A1
20030127049 Han et al. Jul 2003 A1
20030127740 Hsu et al. Jul 2003 A1
20030129106 Sorensen et al. Jul 2003 A1
20030129827 Lee et al. Jul 2003 A1
20030132319 Hytros et al. Jul 2003 A1
20030136520 Yudovsky et al. Jul 2003 A1
20030140844 Maa et al. Jul 2003 A1
20030143328 Chen et al. Jul 2003 A1
20030148035 Lingampalli Aug 2003 A1
20030150530 Lin et al. Aug 2003 A1
20030152691 Baude et al. Aug 2003 A1
20030159307 Sago et al. Aug 2003 A1
20030164226 Kanno et al. Sep 2003 A1
20030168439 Kanno et al. Sep 2003 A1
20030170945 Igeta et al. Sep 2003 A1
20030173333 Wang et al. Sep 2003 A1
20030173347 Guiver Sep 2003 A1
20030173675 Watanabe Sep 2003 A1
20030181040 Ivanov et al. Sep 2003 A1
20030183244 Rossman Oct 2003 A1
20030190426 Padhi et al. Oct 2003 A1
20030196760 Tyler et al. Oct 2003 A1
20030199170 Li Oct 2003 A1
20030200929 Otsuki Oct 2003 A1
20030205329 Gujer et al. Nov 2003 A1
20030205479 Lin et al. Nov 2003 A1
20030209323 Yokogaki et al. Nov 2003 A1
20030215570 Seutter et al. Nov 2003 A1
20030215963 AmRhein et al. Nov 2003 A1
20030216044 Lin et al. Nov 2003 A1
20030221780 Lei et al. Dec 2003 A1
20030224217 Byun et al. Dec 2003 A1
20030224617 Baek et al. Dec 2003 A1
20030230385 Bach et al. Dec 2003 A1
20040002221 O'Donnell et al. Jan 2004 A1
20040003828 Jackson Jan 2004 A1
20040005726 Huang Jan 2004 A1
20040018304 Chung et al. Jan 2004 A1
20040020801 Solling Feb 2004 A1
20040026371 Nguyen et al. Feb 2004 A1
20040033678 Arghavani et al. Feb 2004 A1
20040033684 Li Feb 2004 A1
20040050328 Kumagai et al. Mar 2004 A1
20040058070 Takeuchi et al. Mar 2004 A1
20040058293 Nguyen et al. Mar 2004 A1
20040060514 Janakiraman et al. Apr 2004 A1
20040061447 Saigusa et al. Apr 2004 A1
20040069225 Fairbairn et al. Apr 2004 A1
20040070346 Choi Apr 2004 A1
20040072446 Liu et al. Apr 2004 A1
20040076529 Gnauck et al. Apr 2004 A1
20040083967 Yuda et al. May 2004 A1
20040087139 Yeh et al. May 2004 A1
20040092063 Okumura et al. May 2004 A1
20040099285 Wange et al. May 2004 A1
20040099378 Kim et al. May 2004 A1
20040101667 O'Loughlin et al. May 2004 A1
20040103844 Chou et al. Jun 2004 A1
20040107908 Collins et al. Jun 2004 A1
20040108067 Fischione et al. Jun 2004 A1
20040108068 Senzaki et al. Jun 2004 A1
20040115876 Goundar et al. Jun 2004 A1
20040115947 Fink et al. Jun 2004 A1
20040124280 Shih et al. Jul 2004 A1
20040129671 Ji et al. Jul 2004 A1
20040137161 Segawa et al. Jul 2004 A1
20040140053 Srivastava et al. Jul 2004 A1
20040144311 Chen et al. Jul 2004 A1
20040144490 Zhao et al. Jul 2004 A1
20040147126 Yamashita et al. Jul 2004 A1
20040149223 Collison et al. Aug 2004 A1
20040149387 Kim et al. Aug 2004 A1
20040149394 Doan et al. Aug 2004 A1
20040152342 Li Aug 2004 A1
20040154535 Chen et al. Aug 2004 A1
20040157444 Chiu Aug 2004 A1
20040161921 Ryu Aug 2004 A1
20040163601 Kadotani et al. Aug 2004 A1
20040175913 Johnson et al. Sep 2004 A1
20040175929 Schmitt et al. Sep 2004 A1
20040182315 Laflamme et al. Sep 2004 A1
20040187787 Dawson Sep 2004 A1
20040192032 Ohmori et al. Sep 2004 A1
20040194799 Kim et al. Oct 2004 A1
20040195208 Pavel et al. Oct 2004 A1
20040195216 Strang Oct 2004 A1
20040200499 Harvey Oct 2004 A1
20040211357 Gadgil et al. Oct 2004 A1
20040219723 Peng et al. Nov 2004 A1
20040219737 Quon Nov 2004 A1
20040219789 Wood et al. Nov 2004 A1
20040221809 Ohmi et al. Nov 2004 A1
20040231706 Bhatnagar et al. Nov 2004 A1
20040237897 Hanawa et al. Dec 2004 A1
20040238123 Becknell et al. Dec 2004 A1
20040259367 Constantine et al. Dec 2004 A1
20040263827 Xu Dec 2004 A1
20050000430 Jang et al. Jan 2005 A1
20050000432 Keller et al. Jan 2005 A1
20050001276 Gao et al. Jan 2005 A1
20050003676 Ho et al. Jan 2005 A1
20050009340 Saijo et al. Jan 2005 A1
20050009358 Choi et al. Jan 2005 A1
20050026430 Kim et al. Feb 2005 A1
20050026431 Kazumi et al. Feb 2005 A1
20050035455 Hu et al. Feb 2005 A1
20050039679 Kleshock Feb 2005 A1
20050051094 Schaepkens et al. Mar 2005 A1
20050054167 Choi et al. Mar 2005 A1
20050056218 Sun et al. Mar 2005 A1
20050073051 Yamamoto et al. Apr 2005 A1
20050079706 Kumar et al. Apr 2005 A1
20050087517 Ott et al. Apr 2005 A1
20050090078 Ishihara Apr 2005 A1
20050090120 Hasegawa et al. Apr 2005 A1
20050098111 Shimizu et al. May 2005 A1
20050103267 Hur et al. May 2005 A1
20050105991 Hofmeister et al. May 2005 A1
20050109279 Suzuki May 2005 A1
20050112876 Wu May 2005 A1
20050112901 Ji et al. May 2005 A1
20050123690 Derderian et al. Jun 2005 A1
20050133849 Jeon et al. Jun 2005 A1
20050136188 Chang Jun 2005 A1
20050145341 Suzuki Jul 2005 A1
20050164479 Perng et al. Jul 2005 A1
20050167394 Liu et al. Aug 2005 A1
20050176258 Hirose et al. Aug 2005 A1
20050178746 Gorin Aug 2005 A1
20050181588 Kim Aug 2005 A1
20050183666 Tsuji et al. Aug 2005 A1
20050194094 Yasaka Sep 2005 A1
20050196967 Savas et al. Sep 2005 A1
20050199489 Stevens et al. Sep 2005 A1
20050205110 Kao et al. Sep 2005 A1
20050205862 Koemtzopoulos et al. Sep 2005 A1
20050208215 Eguchi et al. Sep 2005 A1
20050208217 Shinriki et al. Sep 2005 A1
20050214477 Hanawa et al. Sep 2005 A1
20050217582 Kim et al. Oct 2005 A1
20050218507 Kao et al. Oct 2005 A1
20050219786 Brown et al. Oct 2005 A1
20050221552 Kao et al. Oct 2005 A1
20050224181 Merry et al. Oct 2005 A1
20050229848 Shinriki et al. Oct 2005 A1
20050230350 Kao et al. Oct 2005 A1
20050236694 Wu et al. Oct 2005 A1
20050238807 Lin et al. Oct 2005 A1
20050239282 Chen et al. Oct 2005 A1
20050241763 Huang et al. Nov 2005 A1
20050251990 Choi et al. Nov 2005 A1
20050266622 Arghavani et al. Dec 2005 A1
20050266650 Ahn et al. Dec 2005 A1
20050266691 Gu et al. Dec 2005 A1
20050269030 Kent et al. Dec 2005 A1
20050274324 Takahashi et al. Dec 2005 A1
20050279454 Snijders Dec 2005 A1
20050283321 Yue et al. Dec 2005 A1
20050287688 Won et al. Dec 2005 A1
20050287755 Bachmann Dec 2005 A1
20050287771 Seamons et al. Dec 2005 A1
20060000802 Kumar et al. Jan 2006 A1
20060000805 Todorow et al. Jan 2006 A1
20060005856 Sun et al. Jan 2006 A1
20060005930 Ikeda et al. Jan 2006 A1
20060006057 Laermer Jan 2006 A1
20060008676 Ebata et al. Jan 2006 A1
20060011298 Lim et al. Jan 2006 A1
20060011299 Condrashoff et al. Jan 2006 A1
20060016783 Wu et al. Jan 2006 A1
20060019456 Bu et al. Jan 2006 A1
20060019477 Hanawa et al. Jan 2006 A1
20060019486 Yu et al. Jan 2006 A1
20060021574 Armour et al. Feb 2006 A1
20060021701 Tobe et al. Feb 2006 A1
20060021703 Umotoy et al. Feb 2006 A1
20060024954 Wu et al. Feb 2006 A1
20060024956 Zhijian et al. Feb 2006 A1
20060033678 Lubomirsky et al. Feb 2006 A1
20060040055 Nguyen et al. Feb 2006 A1
20060043066 Kamp Mar 2006 A1
20060046412 Nguyen et al. Mar 2006 A1
20060046419 Sandhu et al. Mar 2006 A1
20060046470 Becknell Mar 2006 A1
20060051966 Or et al. Mar 2006 A1
20060051968 Joshi et al. Mar 2006 A1
20060054184 Mozetic et al. Mar 2006 A1
20060054280 Jang Mar 2006 A1
20060057828 Omura et al. Mar 2006 A1
20060060942 Minixhofer et al. Mar 2006 A1
20060065629 Chen et al. Mar 2006 A1
20060073349 Aihara et al. Apr 2006 A1
20060076108 Holland et al. Apr 2006 A1
20060087644 McMillin et al. Apr 2006 A1
20060090700 Satoh et al. May 2006 A1
20060093756 Rajagopalan et al. May 2006 A1
20060097397 Russell et al. May 2006 A1
20060102076 Smith et al. May 2006 A1
20060102587 Kimura May 2006 A1
20060113038 Gondhalekar et al. Jun 2006 A1
20060118178 Desbiolles et al. Jun 2006 A1
20060118240 Holber et al. Jun 2006 A1
20060121724 Yue et al. Jun 2006 A1
20060124151 Yamasaki et al. Jun 2006 A1
20060124242 Kanarik et al. Jun 2006 A1
20060130971 Chang et al. Jun 2006 A1
20060151115 Kim et al. Jul 2006 A1
20060157449 Takahashi et al. Jul 2006 A1
20060162661 Jung et al. Jul 2006 A1
20060166107 Chen et al. Jul 2006 A1
20060166515 Karim et al. Jul 2006 A1
20060169327 Shajii et al. Aug 2006 A1
20060169410 Maeda et al. Aug 2006 A1
20060178008 Yeh et al. Aug 2006 A1
20060183270 Humpston Aug 2006 A1
20060185592 Matsuura Aug 2006 A1
20060191479 Mizukami et al. Aug 2006 A1
20060191637 Zajac et al. Aug 2006 A1
20060207504 Hasebe et al. Sep 2006 A1
20060207595 Ohmi et al. Sep 2006 A1
20060207971 Moriya et al. Sep 2006 A1
20060210713 Brcka Sep 2006 A1
20060210723 Ishizaka Sep 2006 A1
20060215347 Wakabayashi et al. Sep 2006 A1
20060216878 Lee Sep 2006 A1
20060219360 Iwasaki Oct 2006 A1
20060222481 Foree Oct 2006 A1
20060226121 Aoi Oct 2006 A1
20060228889 Edelberg et al. Oct 2006 A1
20060240661 Annapragada et al. Oct 2006 A1
20060244107 Sugihara Nov 2006 A1
20060245852 Iwabuchi Nov 2006 A1
20060246217 Weidman et al. Nov 2006 A1
20060251800 Weidman et al. Nov 2006 A1
20060251801 Weidman et al. Nov 2006 A1
20060252252 Zhu et al. Nov 2006 A1
20060252265 Jin et al. Nov 2006 A1
20060254716 Mosden et al. Nov 2006 A1
20060260750 Rueger Nov 2006 A1
20060261490 Su et al. Nov 2006 A1
20060264043 Stewart et al. Nov 2006 A1
20060266288 Choi Nov 2006 A1
20060286774 Singh et al. Dec 2006 A1
20060289384 Pavel et al. Dec 2006 A1
20060292846 Pinto et al. Dec 2006 A1
20070022952 Ritchie et al. Feb 2007 A1
20070025907 Rezeq Feb 2007 A1
20070039548 Johnson Feb 2007 A1
20070048977 Lee et al. Mar 2007 A1
20070051471 Kawaguchi et al. Mar 2007 A1
20070056925 Liu et al. Mar 2007 A1
20070062453 Ishikawa Mar 2007 A1
20070066084 Wajda et al. Mar 2007 A1
20070071888 Shanmugasundram et al. Mar 2007 A1
20070072408 Enomoto et al. Mar 2007 A1
20070077737 Kobayashi Apr 2007 A1
20070079758 Holland et al. Apr 2007 A1
20070090325 Hwang et al. Apr 2007 A1
20070099428 Shamiryan et al. May 2007 A1
20070099431 Li May 2007 A1
20070099438 Ye et al. May 2007 A1
20070107750 Sawin et al. May 2007 A1
20070108404 Stewart et al. May 2007 A1
20070111519 Lubomirsky et al. May 2007 A1
20070117396 Wu et al. May 2007 A1
20070119370 Ma et al. May 2007 A1
20070119371 Ma et al. May 2007 A1
20070123051 Arghavani et al. May 2007 A1
20070128864 Ma Jun 2007 A1
20070131274 Stollwerck et al. Jun 2007 A1
20070145023 Holber et al. Jun 2007 A1
20070154838 Lee Jul 2007 A1
20070163440 Kim et al. Jul 2007 A1
20070175861 Hwang et al. Aug 2007 A1
20070181057 Lam et al. Aug 2007 A1
20070193515 Jeon et al. Aug 2007 A1
20070197028 Byun et al. Aug 2007 A1
20070207275 Nowak et al. Sep 2007 A1
20070212288 Holst Sep 2007 A1
20070221620 Sakthivel et al. Sep 2007 A1
20070227554 Satoh et al. Oct 2007 A1
20070231109 Pak et al. Oct 2007 A1
20070232071 Balseanu et al. Oct 2007 A1
20070235134 Limuro Oct 2007 A1
20070235136 Enomoto et al. Oct 2007 A1
20070238199 Yamashita Oct 2007 A1
20070238321 Futase et al. Oct 2007 A1
20070243685 Jiang et al. Oct 2007 A1
20070243714 Shin et al. Oct 2007 A1
20070254169 Kamins et al. Nov 2007 A1
20070258186 Matyushkin et al. Nov 2007 A1
20070259467 Tweet et al. Nov 2007 A1
20070264820 Liu Nov 2007 A1
20070266946 Choi Nov 2007 A1
20070277734 Lubomirsky et al. Dec 2007 A1
20070280816 Kurita et al. Dec 2007 A1
20070281106 Lubomirsky et al. Dec 2007 A1
20070284044 Matsumoto et al. Dec 2007 A1
20070287292 Li et al. Dec 2007 A1
20070296967 Gupta et al. Dec 2007 A1
20080003836 Nishimura et al. Jan 2008 A1
20080011424 Yin et al. Jan 2008 A1
20080017104 Matyushkin et al. Jan 2008 A1
20080020570 Naik Jan 2008 A1
20080029032 Sun et al. Feb 2008 A1
20080035608 Thomas et al. Feb 2008 A1
20080044593 Seo et al. Feb 2008 A1
20080044990 Lee Feb 2008 A1
20080050538 Hirata Feb 2008 A1
20080063810 Park et al. Mar 2008 A1
20080075668 Goldstein Mar 2008 A1
20080081483 Wu Apr 2008 A1
20080085604 Hoshino et al. Apr 2008 A1
20080099147 Myo et al. May 2008 A1
20080099431 Kumar et al. May 2008 A1
20080099876 Seto May 2008 A1
20080100222 Lewington et al. May 2008 A1
20080102570 Fischer et al. May 2008 A1
20080102640 Hassan et al. May 2008 A1
20080102646 Kawaguchi et al. May 2008 A1
20080104782 Hughes May 2008 A1
20080105555 Iwazaki et al. May 2008 A1
20080115726 Ingle et al. May 2008 A1
20080121970 Aritome May 2008 A1
20080124937 Xu et al. May 2008 A1
20080141941 Augustino et al. Jun 2008 A1
20080142831 Su Jun 2008 A1
20080153306 Cho et al. Jun 2008 A1
20080156631 Fair et al. Jul 2008 A1
20080156771 Jeon et al. Jul 2008 A1
20080157225 Datta et al. Jul 2008 A1
20080160210 Yang et al. Jul 2008 A1
20080169588 Shih et al. Jul 2008 A1
20080171407 Nakabayashi et al. Jul 2008 A1
20080173906 Zhu Jul 2008 A1
20080176412 Komeda Jul 2008 A1
20080178797 Fodor et al. Jul 2008 A1
20080178805 Paterson et al. Jul 2008 A1
20080182381 Kiyotoshi Jul 2008 A1
20080182382 Ingle et al. Jul 2008 A1
20080182383 Lee et al. Jul 2008 A1
20080193673 Paterson et al. Aug 2008 A1
20080196666 Toshima Aug 2008 A1
20080202688 Wu et al. Aug 2008 A1
20080202892 Smith et al. Aug 2008 A1
20080213496 Sun et al. Sep 2008 A1
20080216901 Chamberlain et al. Sep 2008 A1
20080216958 Goto et al. Sep 2008 A1
20080230519 Takahashi Sep 2008 A1
20080233709 Conti et al. Sep 2008 A1
20080236751 Aramaki et al. Oct 2008 A1
20080254635 Benzel et al. Oct 2008 A1
20080261404 Kozuka et al. Oct 2008 A1
20080264337 Sano et al. Oct 2008 A1
20080268645 Kao et al. Oct 2008 A1
20080292798 Huh et al. Nov 2008 A1
20080293248 Park et al. Nov 2008 A1
20080317965 Son et al. Dec 2008 A1
20090000743 Iizuka Jan 2009 A1
20090001480 Cheng Jan 2009 A1
20090004849 Eun Jan 2009 A1
20090004873 Yang Jan 2009 A1
20090014127 Shah et al. Jan 2009 A1
20090014323 Yendler et al. Jan 2009 A1
20090014324 Kawaguchi et al. Jan 2009 A1
20090017227 Fu et al. Jan 2009 A1
20090022633 Tomosue et al. Jan 2009 A1
20090036292 Sun et al. Feb 2009 A1
20090045167 Maruyama Feb 2009 A1
20090061640 Wong et al. Mar 2009 A1
20090072401 Arnold et al. Mar 2009 A1
20090081878 Dhindsa Mar 2009 A1
20090084317 Wu et al. Apr 2009 A1
20090087960 Cho et al. Apr 2009 A1
20090087979 Raghuram Apr 2009 A1
20090095221 Tam et al. Apr 2009 A1
20090095222 Tam et al. Apr 2009 A1
20090095621 Kao et al. Apr 2009 A1
20090098276 Burrows Apr 2009 A1
20090098706 Kim et al. Apr 2009 A1
20090104738 Ring et al. Apr 2009 A1
20090104782 Lu et al. Apr 2009 A1
20090111280 Kao et al. Apr 2009 A1
20090117270 Yamasaki et al. May 2009 A1
20090120464 Rasheed et al. May 2009 A1
20090159213 Bera et al. Jun 2009 A1
20090159588 Morioka et al. Jun 2009 A1
20090162647 Sun et al. Jun 2009 A1
20090170221 Jacques et al. Jul 2009 A1
20090170331 Cheng et al. Jul 2009 A1
20090179300 Arai Jul 2009 A1
20090189246 Wu et al. Jul 2009 A1
20090189287 Yang et al. Jul 2009 A1
20090191711 Rui et al. Jul 2009 A1
20090194233 Tamura Aug 2009 A1
20090194810 Kiyotoshi et al. Aug 2009 A1
20090197418 Sago Aug 2009 A1
20090202721 Nogami et al. Aug 2009 A1
20090214825 Sun et al. Aug 2009 A1
20090223928 Colpo Sep 2009 A1
20090226633 Laflamme et al. Sep 2009 A1
20090236314 Chen Sep 2009 A1
20090253222 Morisawa et al. Oct 2009 A1
20090255902 Satoh et al. Oct 2009 A1
20090258162 Furuta et al. Oct 2009 A1
20090269934 Kao et al. Oct 2009 A1
20090274590 Willwerth et al. Nov 2009 A1
20090275146 Takano et al. Nov 2009 A1
20090275205 Kiehlbauch et al. Nov 2009 A1
20090275206 Katz et al. Nov 2009 A1
20090277587 Lubomirsky et al. Nov 2009 A1
20090277874 Rui et al. Nov 2009 A1
20090280650 Lubomirsky et al. Nov 2009 A1
20090286400 Heo et al. Nov 2009 A1
20090286405 Okesaku et al. Nov 2009 A1
20090293809 Cho et al. Dec 2009 A1
20090294898 Feustel et al. Dec 2009 A1
20090298256 Chen et al. Dec 2009 A1
20090314309 Sankarakrishnan et al. Dec 2009 A1
20090317978 Higashi Dec 2009 A1
20090320756 Tanaka Dec 2009 A1
20100000683 Kadkhodayan et al. Jan 2010 A1
20100003406 Lam et al. Jan 2010 A1
20100003824 Kadkhodayan et al. Jan 2010 A1
20100006543 Sawada et al. Jan 2010 A1
20100022030 Ditizio Jan 2010 A1
20100025370 Dieguez-Campo et al. Feb 2010 A1
20100037821 Nogami Feb 2010 A1
20100039747 Sansoni Feb 2010 A1
20100047080 Bruce Feb 2010 A1
20100048022 Kubota Feb 2010 A1
20100048027 Cheng et al. Feb 2010 A1
20100055408 Lee et al. Mar 2010 A1
20100055917 Kim Mar 2010 A1
20100059889 Gosset et al. Mar 2010 A1
20100062603 Ganguly et al. Mar 2010 A1
20100072172 Ui et al. Mar 2010 A1
20100075503 Bencher Mar 2010 A1
20100081285 Chen et al. Apr 2010 A1
20100089533 Ueda et al. Apr 2010 A1
20100093151 Arghavani et al. Apr 2010 A1
20100093168 Naik Apr 2010 A1
20100096367 Jeon et al. Apr 2010 A1
20100098882 Lubomirsky et al. Apr 2010 A1
20100099236 Kwon et al. Apr 2010 A1
20100099263 Kao et al. Apr 2010 A1
20100101727 Ji Apr 2010 A1
20100105209 Winniczek et al. Apr 2010 A1
20100116788 Singh et al. May 2010 A1
20100119843 Sun et al. May 2010 A1
20100129974 Futase et al. May 2010 A1
20100130001 Noguchi May 2010 A1
20100139889 Kurita et al. Jun 2010 A1
20100144140 Chandrashekar et al. Jun 2010 A1
20100147219 Hsieh et al. Jun 2010 A1
20100151149 Ovshinsky Jun 2010 A1
20100164422 Shu et al. Jul 2010 A1
20100173499 Tao et al. Jul 2010 A1
20100178748 Subramanian Jul 2010 A1
20100178755 Lee et al. Jul 2010 A1
20100180819 Hatanaka et al. Jul 2010 A1
20100183825 Becker et al. Jul 2010 A1
20100187534 Nishi et al. Jul 2010 A1
20100187588 Kim et al. Jul 2010 A1
20100187694 Yu et al. Jul 2010 A1
20100190352 Jaiswal Jul 2010 A1
20100197143 Nishimura Aug 2010 A1
20100203739 Becker et al. Aug 2010 A1
20100206483 Sorensen et al. Aug 2010 A1
20100207195 Fukuzumi et al. Aug 2010 A1
20100207205 Grebs et al. Aug 2010 A1
20100213172 Wilson Aug 2010 A1
20100224322 Sui et al. Sep 2010 A1
20100224324 Kasai Sep 2010 A1
20100240205 Son Sep 2010 A1
20100243165 Um Sep 2010 A1
20100243606 Koshimizu Sep 2010 A1
20100244204 Matsuoka et al. Sep 2010 A1
20100248488 Agarwal et al. Sep 2010 A1
20100252068 Kannan et al. Oct 2010 A1
20100258913 Lue Oct 2010 A1
20100267224 Choi et al. Oct 2010 A1
20100267248 Ma et al. Oct 2010 A1
20100273290 Kryliouk Oct 2010 A1
20100273291 Kryliouk et al. Oct 2010 A1
20100288369 Chang et al. Nov 2010 A1
20100294199 Tran et al. Nov 2010 A1
20100310785 Sasakawa et al. Dec 2010 A1
20100314005 Saito et al. Dec 2010 A1
20100330814 Yokota et al. Dec 2010 A1
20110005607 Desbiolles et al. Jan 2011 A1
20110005684 Hayami et al. Jan 2011 A1
20110008950 Xu Jan 2011 A1
20110011338 Chuc et al. Jan 2011 A1
20110034035 Liang et al. Feb 2011 A1
20110039407 Nishizuka Feb 2011 A1
20110045676 Park Feb 2011 A1
20110048325 Choie et al. Mar 2011 A1
20110053380 Sapre et al. Mar 2011 A1
20110058303 Migita Mar 2011 A1
20110061810 Ganguly et al. Mar 2011 A1
20110061812 Ganguly et al. Mar 2011 A1
20110065276 Ganguly et al. Mar 2011 A1
20110076401 Chao et al. Mar 2011 A1
20110081782 Liang et al. Apr 2011 A1
20110088847 Law et al. Apr 2011 A1
20110100489 Orito May 2011 A1
20110104393 Hilkene et al. May 2011 A1
20110111596 Kanakasabapathy May 2011 A1
20110114601 Lubomirsky et al. May 2011 A1
20110115378 Lubomirsky et al. May 2011 A1
20110124144 Schlemm et al. May 2011 A1
20110127156 Foad et al. Jun 2011 A1
20110133650 Kim Jun 2011 A1
20110139748 Donnelly et al. Jun 2011 A1
20110140229 Rachmady et al. Jun 2011 A1
20110143542 Feurprier et al. Jun 2011 A1
20110146909 Shih et al. Jun 2011 A1
20110147363 Yap et al. Jun 2011 A1
20110151674 Tang et al. Jun 2011 A1
20110151677 Wang et al. Jun 2011 A1
20110151678 Ashtiani et al. Jun 2011 A1
20110155181 Inatomi Jun 2011 A1
20110159690 Chandrashekar et al. Jun 2011 A1
20110165057 Honda et al. Jul 2011 A1
20110165347 Miller et al. Jul 2011 A1
20110165771 Ring et al. Jul 2011 A1
20110174778 Sawada et al. Jul 2011 A1
20110180847 Ikeda et al. Jul 2011 A1
20110195575 Wang Aug 2011 A1
20110198034 Sun et al. Aug 2011 A1
20110204025 Tahara Aug 2011 A1
20110207332 Liu et al. Aug 2011 A1
20110217851 Liang et al. Sep 2011 A1
20110226734 Sumiya et al. Sep 2011 A1
20110227028 Sekar et al. Sep 2011 A1
20110230008 Lakshmanan et al. Sep 2011 A1
20110230052 Tang et al. Sep 2011 A1
20110232737 Ruletzki et al. Sep 2011 A1
20110232845 Riker et al. Sep 2011 A1
20110244686 Aso et al. Oct 2011 A1
20110244693 Tamura et al. Oct 2011 A1
20110256421 Bose et al. Oct 2011 A1
20110265884 Xu et al. Nov 2011 A1
20110265887 Lee et al. Nov 2011 A1
20110265951 Xu et al. Nov 2011 A1
20110266252 Thadani et al. Nov 2011 A1
20110266256 Cruse et al. Nov 2011 A1
20110266682 Edelstein et al. Nov 2011 A1
20110278260 Lai et al. Nov 2011 A1
20110287633 Lee et al. Nov 2011 A1
20110294300 Zhang et al. Dec 2011 A1
20110298061 Siddiqui et al. Dec 2011 A1
20110304078 Lee et al. Dec 2011 A1
20110308453 Su et al. Dec 2011 A1
20120003782 Byun et al. Jan 2012 A1
20120009796 Cui et al. Jan 2012 A1
20120025289 Liang et al. Feb 2012 A1
20120031559 Dhindsa et al. Feb 2012 A1
20120034786 Dhindsa et al. Feb 2012 A1
20120035766 Shajii et al. Feb 2012 A1
20120037596 Eto et al. Feb 2012 A1
20120040492 Ovshinsky et al. Feb 2012 A1
20120052683 Kim et al. Mar 2012 A1
20120055402 Moriya et al. Mar 2012 A1
20120068242 Shin et al. Mar 2012 A1
20120070982 Yu et al. Mar 2012 A1
20120070996 Hao et al. Mar 2012 A1
20120091108 Lin et al. Apr 2012 A1
20120097330 Iyengar et al. Apr 2012 A1
20120100720 Winniczek et al. Apr 2012 A1
20120103518 Kakimoto May 2012 A1
20120104564 Won et al. May 2012 A1
20120119225 Shiomi et al. May 2012 A1
20120122302 Weidman et al. May 2012 A1
20120122319 Shimizu May 2012 A1
20120129354 Luong May 2012 A1
20120135576 Lee et al. May 2012 A1
20120148369 Michalski et al. Jun 2012 A1
20120149200 Culp et al. Jun 2012 A1
20120161405 Mohn et al. Jun 2012 A1
20120164839 Nishimura Jun 2012 A1
20120171852 Yuan et al. Jul 2012 A1
20120180954 Yang et al. Jul 2012 A1
20120181599 Lung Jul 2012 A1
20120182808 Lue et al. Jul 2012 A1
20120187844 Hoffman et al. Jul 2012 A1
20120196447 Yang et al. Aug 2012 A1
20120196451 Mallick Aug 2012 A1
20120202408 Shajii et al. Aug 2012 A1
20120208361 Ha Aug 2012 A1
20120211462 Zhang et al. Aug 2012 A1
20120211722 Kellam et al. Aug 2012 A1
20120222616 Han et al. Sep 2012 A1
20120222815 Sabri et al. Sep 2012 A1
20120223048 Paranjpe et al. Sep 2012 A1
20120223418 Stowers et al. Sep 2012 A1
20120225557 Serry et al. Sep 2012 A1
20120228642 Aube et al. Sep 2012 A1
20120234945 Olgado Sep 2012 A1
20120238102 Zhang et al. Sep 2012 A1
20120238103 Zhang et al. Sep 2012 A1
20120238108 Chen et al. Sep 2012 A1
20120241411 Darling et al. Sep 2012 A1
20120247390 Sawada et al. Oct 2012 A1
20120247670 Dobashi et al. Oct 2012 A1
20120247671 Sugawara Oct 2012 A1
20120247677 Himori et al. Oct 2012 A1
20120255491 Hahidi Oct 2012 A1
20120258600 Godet et al. Oct 2012 A1
20120258607 Holland et al. Oct 2012 A1
20120267346 Kao et al. Oct 2012 A1
20120269968 Rayner Oct 2012 A1
20120282779 Arnold et al. Nov 2012 A1
20120285619 Matyushkin et al. Nov 2012 A1
20120285621 Tan Nov 2012 A1
20120291696 Clarke Nov 2012 A1
20120292664 Kanike Nov 2012 A1
20120304933 Mai et al. Dec 2012 A1
20120309204 Kang et al. Dec 2012 A1
20120309205 Wang et al. Dec 2012 A1
20120322015 Kim Dec 2012 A1
20130001899 Hwang et al. Jan 2013 A1
20130005103 Liu et al. Jan 2013 A1
20130005140 Jeng et al. Jan 2013 A1
20130012030 Lakshmanan et al. Jan 2013 A1
20130012032 Liu et al. Jan 2013 A1
20130023062 Masuda et al. Jan 2013 A1
20130023124 Nemani et al. Jan 2013 A1
20130023125 Singh Jan 2013 A1
20130026135 Kim Jan 2013 A1
20130032574 Liu et al. Feb 2013 A1
20130034666 Liang et al. Feb 2013 A1
20130034968 Zhang et al. Feb 2013 A1
20130037919 Sapra et al. Feb 2013 A1
20130045605 Wang et al. Feb 2013 A1
20130049592 Yeom et al. Feb 2013 A1
20130052804 Song Feb 2013 A1
20130052827 Wang et al. Feb 2013 A1
20130052833 Ranjan et al. Feb 2013 A1
20130059440 Wang et al. Mar 2013 A1
20130059448 Marakhtanov et al. Mar 2013 A1
20130062675 Thomas Mar 2013 A1
20130065398 Ohsawa et al. Mar 2013 A1
20130082197 Yang et al. Apr 2013 A1
20130084654 Gaylord et al. Apr 2013 A1
20130087309 Volfovski Apr 2013 A1
20130089988 Wang et al. Apr 2013 A1
20130095646 Alsmeier et al. Apr 2013 A1
20130098868 Nishimura et al. Apr 2013 A1
20130105303 Lubomirsky et al. May 2013 A1
20130105948 Kewley May 2013 A1
20130115372 Pavol et al. May 2013 A1
20130118686 Carducci et al. May 2013 A1
20130119016 Kagoshima May 2013 A1
20130119457 Lue et al. May 2013 A1
20130119483 Alptekin et al. May 2013 A1
20130130507 Wang et al. May 2013 A1
20130133578 Hwang May 2013 A1
20130150303 Kungl et al. Jun 2013 A1
20130155568 Todorow et al. Jun 2013 A1
20130161726 Kim et al. Jun 2013 A1
20130171810 Sun et al. Jul 2013 A1
20130175654 Muckenhirn et al. Jul 2013 A1
20130187220 Surthi Jul 2013 A1
20130193108 Zheng Aug 2013 A1
20130213935 Liao et al. Aug 2013 A1
20130217243 Underwood et al. Aug 2013 A1
20130224953 Salinas et al. Aug 2013 A1
20130224960 Payyapilly et al. Aug 2013 A1
20130260533 Sapre et al. Oct 2013 A1
20130260564 Sapre et al. Oct 2013 A1
20130279066 Lubomirsky et al. Oct 2013 A1
20130284369 Kobayashi et al. Oct 2013 A1
20130284370 Kobayashi et al. Oct 2013 A1
20130284373 Sun et al. Oct 2013 A1
20130284374 Lubomirsky et al. Oct 2013 A1
20130286530 Lin et al. Oct 2013 A1
20130295297 Chou et al. Nov 2013 A1
20130298942 Ren et al. Nov 2013 A1
20130302980 Chandrashekar et al. Nov 2013 A1
20130320550 Kim Dec 2013 A1
20130337655 Lee et al. Dec 2013 A1
20130343829 Benedetti et al. Dec 2013 A1
20140004707 Thedjoisworo et al. Jan 2014 A1
20140004708 Thedjoisworo Jan 2014 A1
20140008880 Miura et al. Jan 2014 A1
20140020708 Kim et al. Jan 2014 A1
20140021673 Chen et al. Jan 2014 A1
20140026813 Wang et al. Jan 2014 A1
20140053866 Baluja et al. Feb 2014 A1
20140054269 Hudson et al. Feb 2014 A1
20140057447 Yang et al. Feb 2014 A1
20140062285 Chen Mar 2014 A1
20140065827 Kang et al. Mar 2014 A1
20140065842 Anthis et al. Mar 2014 A1
20140076234 Kao et al. Mar 2014 A1
20140080308 Chen et al. Mar 2014 A1
20140080309 Park Mar 2014 A1
20140080310 Chen et al. Mar 2014 A1
20140083362 Lubomirsky et al. Mar 2014 A1
20140087488 Nam et al. Mar 2014 A1
20140097270 Liang et al. Apr 2014 A1
20140099794 Ingle et al. Apr 2014 A1
20140102367 Ishibashi Apr 2014 A1
20140110061 Okunishi Apr 2014 A1
20140124364 Yoo et al. May 2014 A1
20140134842 Zhange et al. May 2014 A1
20140134847 Seya May 2014 A1
20140141621 Ren et al. May 2014 A1
20140147126 Yamashita et al. May 2014 A1
20140152312 Snow et al. Jun 2014 A1
20140154668 Chou et al. Jun 2014 A1
20140154889 Wang et al. Jun 2014 A1
20140165912 Kao et al. Jun 2014 A1
20140166617 Chen Jun 2014 A1
20140166618 Tadigadapa et al. Jun 2014 A1
20140175530 Chien et al. Jun 2014 A1
20140175534 Kofuji et al. Jun 2014 A1
20140186772 Pohlers et al. Jul 2014 A1
20140190410 Kim Jul 2014 A1
20140190632 Kumar et al. Jul 2014 A1
20140191388 Chen Jul 2014 A1
20140199850 Kim et al. Jul 2014 A1
20140199851 Nemani et al. Jul 2014 A1
20140209245 Yamamoto et al. Jul 2014 A1
20140216337 Swaminathan et al. Aug 2014 A1
20140225504 Kaneko et al. Aug 2014 A1
20140227881 Lubomirsky et al. Aug 2014 A1
20140234466 Gao et al. Aug 2014 A1
20140248773 Tsai et al. Sep 2014 A1
20140248780 Ingle et al. Sep 2014 A1
20140251956 Jeon et al. Sep 2014 A1
20140256131 Wang et al. Sep 2014 A1
20140256145 Abdallah et al. Sep 2014 A1
20140262031 Belostotskiy et al. Sep 2014 A1
20140262038 Wang et al. Sep 2014 A1
20140263172 Xie et al. Sep 2014 A1
20140263272 Duan et al. Sep 2014 A1
20140264507 Lee et al. Sep 2014 A1
20140264533 Simsek-Ege Sep 2014 A1
20140271097 Wang et al. Sep 2014 A1
20140273373 Makala et al. Sep 2014 A1
20140273406 Wang et al. Sep 2014 A1
20140273451 Wang et al. Sep 2014 A1
20140273462 Simsek-Ege et al. Sep 2014 A1
20140273487 Deshmukh et al. Sep 2014 A1
20140273489 Wang et al. Sep 2014 A1
20140273491 Zhang et al. Sep 2014 A1
20140273492 Anthis et al. Sep 2014 A1
20140273496 Kao Sep 2014 A1
20140288528 Py et al. Sep 2014 A1
20140302678 Paterson et al. Oct 2014 A1
20140302680 Singh Oct 2014 A1
20140308758 Nemani et al. Oct 2014 A1
20140308816 Wang et al. Oct 2014 A1
20140311581 Belostotskiy et al. Oct 2014 A1
20140342532 Zhu Nov 2014 A1
20140342569 Zhu et al. Nov 2014 A1
20140349477 Chandrashekar et al. Nov 2014 A1
20140357083 Ling et al. Dec 2014 A1
20140361684 Ikeda et al. Dec 2014 A1
20140363977 Morimoto et al. Dec 2014 A1
20140363979 Or et al. Dec 2014 A1
20150007770 Chandrasekharan et al. Jan 2015 A1
20150011096 Chandrasekharan et al. Jan 2015 A1
20150014152 Hoinkis et al. Jan 2015 A1
20150031211 Sapre et al. Jan 2015 A1
20150037980 Rha Feb 2015 A1
20150041430 Yoshino et al. Feb 2015 A1
20150050812 Smith Feb 2015 A1
20150056814 Ling et al. Feb 2015 A1
20150060265 Cho et al. Mar 2015 A1
20150064918 Ranjan et al. Mar 2015 A1
20150072508 Or et al. Mar 2015 A1
20150076110 Wu et al. Mar 2015 A1
20150076586 Rabkin et al. Mar 2015 A1
20150079797 Chen et al. Mar 2015 A1
20150093891 Zope Apr 2015 A1
20150118822 Zhang et al. Apr 2015 A1
20150118858 Takaba Apr 2015 A1
20150123541 Baek et al. May 2015 A1
20150126035 Diao et al. May 2015 A1
20150126039 Korolik et al. May 2015 A1
20150126040 Korolik et al. May 2015 A1
20150129541 Wang et al. May 2015 A1
20150129545 Ingle et al. May 2015 A1
20150129546 Ingle et al. May 2015 A1
20150132953 Nowling May 2015 A1
20150132968 Ren et al. May 2015 A1
20150140827 Kao et al. May 2015 A1
20150152072 Cantat et al. Jun 2015 A1
20150155177 Zhang et al. Jun 2015 A1
20150167705 Lee et al. Jun 2015 A1
20150170879 Nguyen et al. Jun 2015 A1
20150170920 Purayath et al. Jun 2015 A1
20150170924 Nguyen et al. Jun 2015 A1
20150170926 Michalak Jun 2015 A1
20150170935 Wang et al. Jun 2015 A1
20150170943 Nguyen et al. Jun 2015 A1
20150171008 Luo Jun 2015 A1
20150179464 Wang et al. Jun 2015 A1
20150187625 Busche et al. Jul 2015 A1
20150191823 Banna et al. Jul 2015 A1
20150194435 Lee Jul 2015 A1
20150200042 Ling et al. Jul 2015 A1
20150206764 Wang et al. Jul 2015 A1
20150214066 Luere et al. Jul 2015 A1
20150214067 Zhang et al. Jul 2015 A1
20150214092 Purayath et al. Jul 2015 A1
20150214337 Ko et al. Jul 2015 A1
20150221479 Chen et al. Aug 2015 A1
20150221541 Nemani et al. Aug 2015 A1
20150228456 Zheng et al. Aug 2015 A1
20150235809 Ito et al. Aug 2015 A1
20150235860 Tomura et al. Aug 2015 A1
20150235863 Chen Aug 2015 A1
20150235865 Wang et al. Aug 2015 A1
20150235867 Nishizuka Aug 2015 A1
20150247231 Nguyen et al. Sep 2015 A1
20150249018 Park et al. Sep 2015 A1
20150255481 Baenninger et al. Sep 2015 A1
20150270140 Gupta et al. Sep 2015 A1
20150275361 Lubomirsky et al. Oct 2015 A1
20150275375 Kim et al. Oct 2015 A1
20150279687 Xue et al. Oct 2015 A1
20150294980 Lee et al. Oct 2015 A1
20150303031 Choi Oct 2015 A1
20150332930 Wang et al. Nov 2015 A1
20150332953 Futase et al. Nov 2015 A1
20150340225 Kim et al. Nov 2015 A1
20150340371 Lue Nov 2015 A1
20150345029 Wang et al. Dec 2015 A1
20150357201 Chen et al. Dec 2015 A1
20150357205 Wang et al. Dec 2015 A1
20150371861 Li et al. Dec 2015 A1
20150371864 Hsu et al. Dec 2015 A1
20150371865 Chen et al. Dec 2015 A1
20150371866 Chen et al. Dec 2015 A1
20150380419 Gunji-Yoneoka et al. Dec 2015 A1
20150380431 Kanamori et al. Dec 2015 A1
20160005572 Liang et al. Jan 2016 A1
20160005833 Collins et al. Jan 2016 A1
20160020071 Khaja et al. Jan 2016 A1
20160027654 Kim et al. Jan 2016 A1
20160027673 Wang et al. Jan 2016 A1
20160035586 Purayath et al. Feb 2016 A1
20160035614 Purayath et al. Feb 2016 A1
20160042920 Cho et al. Feb 2016 A1
20160042968 Purayath et al. Feb 2016 A1
20160043099 Purayath et al. Feb 2016 A1
20160056167 Wang et al. Feb 2016 A1
20160056235 Lee et al. Feb 2016 A1
20160064212 Thedjoisworo et al. Mar 2016 A1
20160064233 Wang et al. Mar 2016 A1
20160079062 Zheng et al. Mar 2016 A1
20160079072 Wang et al. Mar 2016 A1
20160086772 Khaja Mar 2016 A1
20160086807 Park et al. Mar 2016 A1
20160086808 Zhang et al. Mar 2016 A1
20160086815 Pandit et al. Mar 2016 A1
20160086816 Wang et al. Mar 2016 A1
20160093505 Chen et al. Mar 2016 A1
20160093506 Chen et al. Mar 2016 A1
20160093737 Li et al. Mar 2016 A1
20160104606 Park et al. Apr 2016 A1
20160109863 Valcore et al. Apr 2016 A1
20160117425 Povolny et al. Apr 2016 A1
20160118227 Valcore et al. Apr 2016 A1
20160118268 Ingle et al. Apr 2016 A1
20160118396 Rabkin et al. Apr 2016 A1
20160126118 Chen et al. May 2016 A1
20160133480 Ko et al. May 2016 A1
20160136660 Song May 2016 A1
20160141419 Baenninger et al. May 2016 A1
20160148805 Jongbloed et al. May 2016 A1
20160148821 Singh et al. May 2016 A1
20160163512 Lubomirsky Jun 2016 A1
20160163513 Lubomirsky Jun 2016 A1
20160172216 Marakhtanov et al. Jun 2016 A1
20160181112 Xue et al. Jun 2016 A1
20160181116 Berry et al. Jun 2016 A1
20160189933 Kobayashi et al. Jun 2016 A1
20160190147 Kato et al. Jun 2016 A1
20160196969 Berry et al. Jul 2016 A1
20160196984 Lill et al. Jul 2016 A1
20160196985 Tan et al. Jul 2016 A1
20160203958 Arase et al. Jul 2016 A1
20160204009 Nguyen et al. Jul 2016 A1
20160208395 Ooshima Jul 2016 A1
20160218018 Lieu et al. Jul 2016 A1
20160222522 Wang et al. Aug 2016 A1
20160225651 Tran et al. Aug 2016 A1
20160225652 Tran et al. Aug 2016 A1
20160237570 Tan et al. Aug 2016 A1
20160240353 Nagami Aug 2016 A1
20160240389 Zhang et al. Aug 2016 A1
20160240402 Park et al. Aug 2016 A1
20160260588 Park et al. Sep 2016 A1
20160260616 Li et al. Sep 2016 A1
20160260619 Zhang et al. Sep 2016 A1
20160284556 Ingle et al. Sep 2016 A1
20160293398 Danek Oct 2016 A1
20160293438 Zhou et al. Oct 2016 A1
20160300694 Yang et al. Oct 2016 A1
20160307772 Choi et al. Oct 2016 A1
20160307773 Lee et al. Oct 2016 A1
20160314961 Liu et al. Oct 2016 A1
20160314985 Yang et al. Oct 2016 A1
20160319452 Eidschun et al. Nov 2016 A1
20160340781 Thomas et al. Nov 2016 A1
20160343548 Howald et al. Nov 2016 A1
20160358793 Okumura et al. Dec 2016 A1
20170011922 Tanimura et al. Jan 2017 A1
20170040175 Xu et al. Feb 2017 A1
20170040190 Benjaminson et al. Feb 2017 A1
20170040191 Benjaminson et al. Feb 2017 A1
20170040207 Purayath Feb 2017 A1
20170040214 Lai et al. Feb 2017 A1
20170053808 Kamp et al. Feb 2017 A1
20170062184 Tran et al. Mar 2017 A1
20170110290 Kobayashi et al. Apr 2017 A1
20170110335 Yang et al. Apr 2017 A1
20170110475 Liu et al. Apr 2017 A1
20170133202 Berry May 2017 A1
20170178894 Stone et al. Jun 2017 A1
20170178899 Kabansky et al. Jun 2017 A1
20170178924 Chen et al. Jun 2017 A1
20170194128 Lai et al. Jul 2017 A1
20170207088 Kwon et al. Jul 2017 A1
20170226637 Lubomirsky et al. Aug 2017 A1
20170229287 Xu et al. Aug 2017 A1
20170229289 Lubomirsky et al. Aug 2017 A1
20170229291 Singh et al. Aug 2017 A1
20170229293 Park et al. Aug 2017 A1
20170229326 Tran et al. Aug 2017 A1
20170229328 Benjaminson et al. Aug 2017 A1
20170229329 Benjaminson et al. Aug 2017 A1
20170236691 Liang et al. Aug 2017 A1
20170236694 Eason et al. Aug 2017 A1
20170250193 Huo Aug 2017 A1
20170294445 Son et al. Oct 2017 A1
20170309509 Tran et al. Oct 2017 A1
20170338133 Tan et al. Nov 2017 A1
20170338134 Tan et al. Nov 2017 A1
20170373082 Sekine et al. Dec 2017 A1
20180005850 Citla et al. Jan 2018 A1
20180006050 Watanabe et al. Jan 2018 A1
20180025900 Park et al. Jan 2018 A1
20180069000 Bergendahl et al. Mar 2018 A1
20180076031 Yan et al. Mar 2018 A1
20180076044 Choi et al. Mar 2018 A1
20180076083 Ko et al. Mar 2018 A1
20180080124 Bajaj Mar 2018 A1
20180082861 Citla et al. Mar 2018 A1
20180096818 Lubomirsky Apr 2018 A1
20180096819 Lubomirsky et al. Apr 2018 A1
20180096821 Lubomirsky et al. Apr 2018 A1
20180096865 Lubomirsky et al. Apr 2018 A1
20180102255 Chen et al. Apr 2018 A1
20180102256 Chen et al. Apr 2018 A1
20180102259 Wang et al. Apr 2018 A1
20180130818 Kim et al. May 2018 A1
20180138049 Ko et al. May 2018 A1
20180138055 Xu et al. May 2018 A1
20180138075 Kang et al. May 2018 A1
20180138085 Wang et al. May 2018 A1
20180175051 Lue et al. Jun 2018 A1
20180182777 Cui et al. Jun 2018 A1
20180223437 George Aug 2018 A1
20180226223 Lubomirsky Aug 2018 A1
20180226230 Kobayashi et al. Aug 2018 A1
20180226259 Choi et al. Aug 2018 A1
20180226278 Arnepalli et al. Aug 2018 A1
20180226425 Purayath Aug 2018 A1
20180226426 Purayath Aug 2018 A1
20180240654 Park et al. Aug 2018 A1
20180261516 Lin et al. Sep 2018 A1
20180261686 Lin et al. Sep 2018 A1
20180315615 Rastogi et al. Nov 2018 A1
20180315616 Rastogi et al. Nov 2018 A1
20180366351 Lubomirsky Dec 2018 A1
Foreign Referenced Citations (94)
Number Date Country
1124364 Jun 1996 CN
1847450 Oct 2006 CN
101236893 Aug 2008 CN
101378850 Mar 2009 CN
12893705 Jan 2013 CN
1675160 Jun 2006 EP
S59-126778 Jul 1984 JP
S62-45119 Feb 1987 JP
63301051 Dec 1988 JP
H01-200627 Aug 1989 JP
H02-114525 Apr 1990 JP
H07-153739 Jun 1995 JP
H8-31755 Feb 1996 JP
H08-107101 Apr 1996 JP
H08-264510 Oct 1996 JP
H09-260356 Oct 1997 JP
2001-313282 Nov 2001 JP
2001-332608 Nov 2001 JP
2002-075972 Mar 2002 JP
2002-083869 Mar 2002 JP
2003-174020 Jun 2003 JP
2003-282591 Oct 2003 JP
2004-508709 Mar 2004 JP
2004-296467 Oct 2004 JP
2005-050908 Feb 2005 JP
2006-041039 Feb 2006 JP
2006-066408 Mar 2006 JP
2008-288560 Nov 2008 JP
4191137 Dec 2008 JP
2009-141343 Jun 2009 JP
2009-530871 Aug 2009 JP
2009-239056 Oct 2009 JP
2010-180458 Aug 2010 JP
2011-508436 Mar 2011 JP
2011-518408 Jun 2011 JP
4763293 Aug 2011 JP
2011-171378 Sep 2011 JP
2012-19164 Jan 2012 JP
2012-019194 Jan 2012 JP
2012-512531 May 2012 JP
2013-243418 Dec 2013 JP
5802323 Oct 2015 JP
2016-111177 Jun 2016 JP
10-2000-008278 Feb 2000 KR
10-2000-0064946 Nov 2000 KR
10-2001-0056735 Jul 2001 KR
2003-0023964 Mar 2003 KR
10-2003-0054726 Jul 2003 KR
10-2003-0083663 Oct 2003 KR
100441297 Jul 2004 KR
10-2005-0007143 Jan 2005 KR
10-2005-0042701 May 2005 KR
2005-0049903 May 2005 KR
10-2006-0080509 Jul 2006 KR
1006-41762 Nov 2006 KR
10-2006-0127173 Dec 2006 KR
100663668 Jan 2007 KR
100678696 Jan 2007 KR
100712727 Apr 2007 KR
2007-0079870 Aug 2007 KR
10-2008-0063988 Jul 2008 KR
10-0843236 Jul 2008 KR
10-2009-0040869 Apr 2009 KR
10-2009-0128913 Dec 2009 KR
10-2010-0013980 Feb 2010 KR
10-2010-0093358 Aug 2010 KR
10-2011-0086540 Jul 2011 KR
10-2011-0114538 Oct 2011 KR
10-2011-0126675 Nov 2011 KR
10-2012-0022251 Mar 2012 KR
10-2012-0082640 Jul 2012 KR
10-2016-0002543 Jan 2016 KR
2006-12480 Apr 2006 TW
200709256 Mar 2007 TW
2007-35196 Sep 2007 TW
2011-27983 Aug 2011 TW
2012-07919 Feb 2012 TW
2012-13594 Apr 2012 TW
2012-33842 Aug 2012 TW
2008-112673 Sep 2008 WO
2009-009611 Jan 2009 WO
2009-084194 Jul 2009 WO
2010-010706 Jan 2010 WO
2010-113946 Oct 2010 WO
2011-027515 Mar 2011 WO
2011-031556 Mar 2011 WO
2011070945 Jun 2011 WO
2011-095846 Aug 2011 WO
2011-149638 Dec 2011 WO
2012-050321 Jul 2012 WO
2012-118987 Sep 2012 WO
2012-125656 Sep 2012 WO
2012-148568 Nov 2012 WO
2013-118260 Aug 2013 WO
Non-Patent Literature Citations (17)
Entry
Won et al.; Sep. 7, 2014, 10 pages.
H. Xiao, Introduction to Semiconductor Manufacturing Technology, published by Prentice Hall, 2001, ISBN 0-13-022404-9, pp. 354-356.
Manual No. TQMA72E1. “Bayard-Alpert Pirani Gauge FRG-730: Short Operating Instructions” Mar. 2012. Agilent Technologies, Lexington, MA 02421, USA. pp. 1-45.
International Search Report and Written Opinion of PCT/US2016/045551 dated Nov. 17, 2016, all pages.
International Search Report and Written Opinion of PCT/US2016/045543 dated Nov. 17, 2016, all pages.
“Liang et al. Industrial Application of Plasma Process vol. 3, pp. 61-74, 2010”.
Instrument Manual: Vacuum Gauge Model MM200, Rev D. TELEVAC (website: www.televac.com), A Division of the Fredericks Company, Huntingdon Valley, PA, US. 2008. pp. 162.
J.J. Wang and et al., “Inductively coupled plasma etching of bulk 1-20 6H-SiC and thin-film SiCN in NF3 chemistries,” Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films 16, 2204 (1998).
International Search Report and Written Opinion of PCT/US2017/047209 dated Nov. 24, 2017, all pages.
International Search Report and Written Opinion of PCT/US2017/033362 dated Aug. 24, 2017, all pages.
International Search Report and Written Opinion of PCT/US2017/060696 dated Jan. 25, 2018, all pages.
International Search Report and Written Opinion of PCT/US2017/055431 dated Jan. 19, 2018, all pages.
Xenon Difluoride, Material Safety Data Sheet; The Linde Group, Revision Date Jun. 6, 2013; Issue Date Feb. 14, 2011: pp. 1-9.
Winters and Coburn, The etching of silicon with XeF2 vapor; AIP Publishing (1979) http.//dx.doi.org/10.1063/1.90562.
Xenon Difluoride XeF2., Data Sheet; The Linde Group, Pullach, Germany; Apr. 7, 2013.
International Search Report and Written Opinion of PCT/US2018/016261 dated May 21, 2018, all pages.
International Search Report and Written Opinion of PCT/US2018/016648 dated May 18, 2018, all pages.
Related Publications (1)
Number Date Country
20190287808 A1 Sep 2019 US